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Abstract
Diabetes is the most common endocrine disorder worldwide with complications that 
include the development of both macro- and micro-vascular disease contributing 
significantly to patient morbidity and mortality. The severity of diabetic 
complications is thought to be amplified during pregnancy, resulting in a higher 
incidence of adverse pregnancy outcomes such as pre-eclampsia, placental 
insufficiency and stillbirth. Vascular dysfunction is thought to underlie many of 
these complications with the greatest effect taking place at the level of the 
resistance vasculature, where even small alterations in vascular reactivity can 
significantly modify blood flow and tissue perfusion. It is likely that problems 
associated with diabetic pregnancies are related, in part, to abnormal vascular 
function particularly dysfunction of the vascular endothelium.
Healthy pregnant women develop progressive insulin resistance and 
hyperinsulinaemia as a result of physiological changes in carbohydrate metabolism. 
Although pathological insulin resistant conditions such as type 2 diabetes and 
obesity are associated with abnormal vascular function, similar changes may not be 
demonstrable in the physiological insulin resistance of normal pregnancy. The 
published literature on the vascular effects in pregnancy and diabetes has been 
extensively reviewed, with emphasis on how modifications in the synthesis, release 
and action of endogenous vasoactive substances may contribute to clinically 
demonstrable pathology. The varying effects of diabetes on different vascular beds, 
in terms of both vessel size and location, reflecting the complexity of disease 
development has been well documented. However, the effect of pregnancy
superimposed on pre-existing type 1 diabetes has never been fully explored. 
Questions still persist regarding the importance of insulin itself as a direct 
vasodilator, its mechanism of action, and how this may alter in the insulin-resistant 
state of pregnancy. There has been little published literature on vascular function in 
pregnant women with type 1 diabetes mellitus, yet a greater understanding of the 
role of endothelium-dependent factors involved in the control of vascular tone is 
important in both healthy and diabetic pregnancies, since they are generally 
considered to be altered in comparison with non-pregnant subjects. The importance 
of endothelium-dependent hyperpolarization in human subcutaneous resistance 
arteries has never been investigated in either diabetes or pregnancy, while the 
implicit importance of endothelin-1 in these conditions requires further 
investigation. This thesis has examined these questions and has produced evidence 
that, in some cases, supports the consensus and, in others, offers new insight.
Those mechanisms most likely to be important in the control of vascular function in 
pregnancy have been examined here using small vessel wire myography, a 
laboratory-based in vitro technique that allows the study of isolated small resistance 
arteries. The direct vasodilator effect of insulin was investigated (Chapter 3) 
providing the first demonstration of an endothelium-independent, insulin-mediated 
attenuation of vascular tone in healthy pregnancy. The role of the vascular 
endothelium in pregnant women with and without diabetes was also examined, with 
particular emphasis on endothelium-dependent relaxing factors. These data provide 
the first confirmation that pregnant women with type 1 diabetes mellitus do not 
demonstrate impaired endothelial function generally considered to be a correlate of 
the diabetic condition, and goes on to provide some support that, in this study
sample at least, this may reflect the level of glycaemic control (Chapter 4). 
Furthermore, the study shows that a non-nitric oxide-dependent endothelial 
hyperpolarization, and not nitric oxide per se, contributes largely to endothelium- 
dependent relaxation in subcutaneous resistance arteries obtained from pregnant 
women whether diabetes is present or not (Chapter 4).
As well as vasodilator mechanisms, alterations in vasoconstrictor control can be 
implicated in a variety of vascular pathologies, including those associated with 
diabetes. Along with its vasodilatory action, insulin is also thought to potentiate the 
release and activity of the potent vasoconstrictor endothelin-1, which may be an 
important contributory factor in diabetic vascular disease. Endothelin-1 is a major 
determinant of vascular tone and has been shown to be associated with disorders of 
pregnancy, such as pre-eclampsia. Examination of endothelin responses in this 
study revealed interesting differences depending on the presence of pregnancy or 
diabetes. A significant increase in the maximum vasoconstriction response to 
endothelin-1 with no change in sensitivity was observed in pregnant compared to 
non-pregnant women. This contrasted with a significant reduction in sensitivity but 
no change in potency (maximum effect) in pregnant women with type 1 diabetes 
compared to healthy pregnant women. These observations clearly point to the 
perturbation of different aspects of endothelin-dependent vasoconstriction 
mechanisms being associated with pregnancy and diabetes (Chapter 5).
Another aspect of metabolic control that is sensitive to both pregnancy and diabetes 
is lipid metabolism. Pregnancy can potentially exacerbate the abnormal lipid 
patterns associated with diabetic patients. Altered lipid profiles can inactivate
endogenous vasodilatory substances, further increasing the risk of endothelial and 
end organ damage. Plasma lipid levels in a small number of pregnant women with 
and without diabetes were assessed and correlated with the in vitro assessments of 
vascular function. Plasma levels of triglycerides, total- and low-density lipoprotein 
(LDL)-cholesterol were increased in pregnant compared to non-pregnant women, 
while plasma high-density lipoprotein (HDL)-choiesterol levels remained 
unchanged. However, the co-existence of diabetes during pregnancy did not appear 
to enhance this effect (Chapter 4).
Together these data suggest that insulin, acting via an endothelium-independent 
mechanism, is an important vasodilator in itself. This effect of insulin is not altered 
in the physiological insulin resistant state of pregnancy. Although underlying 
diabetes does have some effect on the pregnant mother, fears of endothelial 
dysfunction leading to damaging vascular disorders are probably unfounded in well- 
controlled diabetics. Pregnancy per se probably does not increase this risk. The 
observation that endothelial hyperpolarization, rather than nitric oxide, appears 
more important in the endothelial control of vascular tone in small arteries whether 
pregnant or diabetic, supports a very recent growing body of evidence appearing in 
the literature. That endothelin-1 responses can be differentially affected by diabetes 
and pregnancy has never been demonstrated before, and requires further studies to 
understand the mechanisms at work.
In summary, although recent research has focused on therapeutic interventions 
aimed at either restoring or arresting endothelial dysfunction, a real understanding 
of these proposed vascular changes is required. This thesis provides important
insight into the interactions between diabetes and pregnancy and points to those 
areas where further insight and studies are required.
Chapter One
The Effect of Diabetes and Pregnancy 
on Vascular Function
1.1 Introduction
Diabetes mellitus is the most common endocrine disorder affecting approximately 
30 million people worldwide. It is characterised by hyperglycaemia resulting from 
either a deficiency in the production or a decreased effectiveness of insulin, the 
main hormone involved in the regulation of plasma glucose required for cell 
metabolism. The three main types of diabetes mellitus seen in pregnant women are 
type 1 (insulin-dependent) diabetes, type 2 (non-insulin-dependent diabetes) and 
gestational diabetes. Type 1 or insulin-dependent diabetes mellitus is due to an 
inability to produce adequate amounts of insulin and occurs most often in younger 
adults. The majority of diabetics, however, suffer from type 2 diabetes, where there 
is a reduced efficacy of insulin. However, as this is more prevalent in older 
patients, it is seen with relatively less frequency during pregnancy. Gestational 
diabetes refers to women who are shown to be diabetic for the first time during 
pregnancy, with glucose tolerance reverting to normal post-partum. Women who 
suffer from gestational diabetes have a higher incidence of developing type 2 
diabetes in later life.
Diabetes mellitus is associated with significant morbidity and mortality, principally 
due to the development of micro- and macro-angiopathy, increasing the risk of 
cardiovascular disease, stroke, peripheral vascular disease, retinopathy and 
nephropathy (Brownlee and Cerami, 1981; Merimee, 1990; Zatz and Brenner, 
1986). It is estimated that around 3.5 per 1000 pregnancies are affected by diabetes, 
corresponding to approximately 235 women in Scotland each year (Scottish 
Intercollegiate Guidelines Network, 1996). Pregnant women with diabetes have an
increased risk of adverse pregnancy outcomes such as pre-eclampsia, macrosomia 
and stillbirth, while those with pre-existing retinopathy and nephropathy may 
experience rapid deterioration of these conditions (Gamer et a l, 1990; De Swiet, 
1996). Vascular changes, and in particular, endothelial dysfunction, are thought to 
underlie many of these complications, with the greatest effect seen at the level of 
the resistance vasculature where alterations in vessel reactivity can significantly 
alter blood flow and tissue perfusion (Roberts and Redman, 1993; McCarthy et a i, 
1993).
1.2 Normal vascular function
Normal vascular function depends on the integrity of interactions between the 
endothelium and underlying smooth muscle, and is generally subdivided into those 
affecting the endothelium, referred to as endothelium-dependent, and those 
affecting the underlying smooth muscle, referred to as endothelium-independent.
The resistance to blood flow within the circulation is dependent upon the properties 
of the blood vessels and the blood. Although vessels of all sizes can be shown to 
contribute to a greater or lesser extent to resistance in the vascular bed, it is the 
smaller arteries (<500pm) that are most important in regulating capillary pressure 
and blood flow through changes in vascular tone and concomitant alterations in 
vessel diameter (Andersson et a l, 1985; Furness and Marshall, 1974). The control 
of peripheral vascular tone is dependent upon various vasoactive factors, some of 
which are synthesised and released by the endothelium.
The endothelium is a single layer of cells that lines the lumen of the entire vascular 
tree and expresses receptors for circulating hormones (catecholamines, angiotensin 
and vasopressin), and autocoids (bradykinin, serotonin and acetylcholine) 
(Vallance, 1992; Furchgott, 1984). Following activation by various stimuli, these 
receptors mediate a wide range of cellular responses based on different signal 
transduction mechanisms including receptors that;
a) Affect membrane electrical activity and intracellular calcium concentration by 
influencing transmembrane ‘channels’
b) Regulate cyclic adenosine monophosphate (cAMP) formation via adenylate 
cyclase
c) Regulate cyclic guanosine monophosphate (cGMP) formation via guanylate 
cyclase
d) Affect both cytosolic calcium concentration and protein kinase C activity by 
influencing the metabolism of membrane phosphatidyl inositol
e) Possess protein kinase activity
f) Involve a combination of these pathways
This thesis concentrates mainly on those pathways involving receptor-operated 
channels and the cAMP and cGMP second messenger systems.
The endothelium also has autocrine and paracrine effects, and is able to mediate 
vascular responses through the synthesis and release of various vasodilators and 
vasoconstrictors that act on the underlying vascular smooth muscle.
1.2.1 Endothelium-dependent vasodilators
The endothelium is thought to release at least 2 vasodilator substances -nitric oxide 
(NO) and prostacyclin (PGI2). A further possible ‘factor’ is the putative 
endothelium-derived hyperpolarizing factor (EDHF), which is still to be identified 
and is the subject of current research (Fig. 1.1).
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Fig. 1.1 Mechanisms of action of the endogenous endothelium-dependent 
vasodilators -nitric oxide (NO), prostacyclin (PGI2) and endothelium- 
derived hyperpolarizing factor (EDHF). GTP, guanosine triphosphate; 
cGMP, guanosine 3’:5’ cyclic monophosphate; ATP, adenosine 
triphosphate; cAMP, adenosine 3’;5’ cyclic monophosphate; [Ca^’^ i, 
intracellular calcium concentration; intracellular potassium
concentration.
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Nitric oxide (NO)
Nitric oxide is a small, labile, diffusible diatomic radical consisting of a bond order 
of two and a half, and a single unpaired electron. It is a reactive radical with a half- 
life of approximately 6-8 seconds. Nitric oxide is synthesised within the endothelial 
cell from the guanidine-nitrogen terminal of L-arginine in combination with 
molecular oxygen, via the enzyme nitric oxide synthase (NOS). Nitric oxide 
synthase can exist in three different isoforms -Type I, Type II and Type III. The 
constitutive NOS (Type III) is the isoform present in healthy endothelial cells, and 
is calcium-dependent, responding rapidly to changes in intracellular calcium 
concentration.
Nitric oxide is a potent vasodilator that causes relaxation by diffusing across the 
endothelial cell and stimulating soluble guanylate cyclase within vascular smooth 
muscle cells. This, in turn, converts guanosine triphosphate (GTP) to guanosine 
3’;5’ cyclic monophosphate (cGMP). Relaxation results from an accumulation of 
cGMP, which through the cGMP-dependent modification of several intracellular 
processes, reduces intracellular calcium and inhibits the contractile apparatus within 
the vascular smooth muscle cell. However, nitric oxide has also been shown to 
activate potassium channels via cGMP-dependent protein kinase (Robertson et al, 
1993; Taniguchi et a l, 1993), as well as directly activating single calcium- 
dependent potassium channels in cell-free membrane patches without requiring 
cGMP (Bolotina et a l, 1994). Nitric oxide synthesis can be competitively inhibited 
by analogues of L-arginine, such as N®-nitro-L-arginine methyl ester (L-NAME) 
and N“-nitro-L-arginine (L-NOARG). The significant contribution of nitric oxide
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to the control of vascular tone has been demonstrated by studies that have shown 
marked vasoconstriction following nitric oxide inhibition (Vanhoutte et al., 1995; 
Moncada et al., 1991; Rees et a l, 1989; Vallance et a l, 1989).
Prostacyclin (PGI2)
Prostacyclin is an eicosanoid produced primarily by endothelial cells via the 
enzyme, cyclo-oxygenase. In contrast to nitric oxide, prostacyclin causes relaxation 
of vascular smooth muscle by activating adenylate cyclase and increasing the 
production of adenosine 3’:5’ cyclic monophosphate (cAMP). In many vascular 
beds, the contribution of prostacyclin to endothelium-dependent relaxation is 
negligible, contributing to as little as 2% of the total relaxation in some cases (Coats 
et a l, 2001; Kublickiene et a l, 1997; McCarthy et a l, 1994). The relative 
contribution of prostacyclin can be reliably assessed by inhibiting cyclo-oxygenase 
with indomethacin (Coats et a l, 2001; Gerber et al, 1998).
Endothelium-derived hyperpolarizing factor (EDHF)
Before the existence of nitric oxide was recognised, several studies showed that 
acetylcholine could, in fact, hyperpolarize vascular smooth muscle (Kitamura and 
Kuriyama, 1979; Kuriyama and Suzuki, 1978). In the late 1980s, following the 
discovery that endothelium-derived relaxing factor was nitric oxide, 
electrophysiological studies suggested that this hyperpolarization was via an 
‘endothelium-derived hyperpolarizing factor’ distinct from nitric oxide and
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prostacyclin (Palmer et a l, 1987; Komori and Suzuki, 1987; Chen et a l, 1988; 
Félétou and Vanhoutte, 1988).
The precise chemical nature of EDHF remains unknown, and there may be different 
EDHFs depending on the species and vascular bed studied. Its mediation of 
vascular relaxation appears to be entirely dependent on smooth muscle 
hyperpolarization. In human subcutaneous resistance arteries, EDHF has been 
shown to be insensitive to the combined effects of nitric oxide synthase and cyclo- 
oxygenase inhibition, and is thought to be a cytochrome P450 product of 
arachidonic acid (Coats et a l, 2001). In rat hepatic and mesenteric arteries, EDHF 
was reported to be potassium ion released via calcium-dependent potassium 
channels on the vascular endothelium, which then induced membrane 
hyperpolarization and vasorelaxation by activating inwardly-rectifying potassium 
channels and the Na'*’/K‘^ -ATPases on the smooth muscle cells (Edwards et al, 
1998). However, other studies have disagreed with these findings. Lacy et al 
reported that at physiological concentrations of potassium, potassium-induced 
relaxation was different from acetylcholine-mediated relaxation, indicating that 
exogenously-added potassium did not mimic EDHF release by acetylcholine, while 
Doughty et a l concluded that although both EDHF and elevated levels of 
extracellular potassium were able to induce vasorelaxation, they were 
characteristically different (Lacy et a l, 2000; Doughty et a l, 2000).
The failure to identify a single factor as EDHF has led to very recent suggestions 
that endothelial-derived hyperpolarization may be, simply due to the electrical 
propagation across myoendothelial cells (Coleman et a l, 2001a; Coleman et a l,
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2001b; Sandow and Hill, 2000). Despite its unknown chemical nature, endothelial 
hyperpolarization has been shown to be important in the resistance vasculature, 
contributing to -80% of endothelial relaxation in some vascular beds (Shimokawa 
et a l, 1996; Coats et a l, 2001). Furthermore, endothelium-dependent 
hyperpolarization appears to be able to mediate near normal relaxation following 
nitric oxide inhibition, and may be important in the regulation of vascular tone in 
diseases where nitric oxide production or activity is impaired (Kilpatrick and Cocks,
1994).
The effects of endothelial hyperpolarization can be inhibited either by changing the 
cell’s membrane potential using a high (25mM) potassium solution (Gerber et al, 
1998), or through the combined effects of charybdotoxin and apamin, which inhibit 
both large and small potassium conductance channels and the resulting relaxation 
(Zygmunt et a l, 1997; Petersson et a l, 1997).
1.2.2 Endothelium-dependent vasoconstrictors
As well as vasodilators, the endothelium has also been shown to initiate 
vasoconstriction through the release of various diffusible substances known as the 
endothelimn-derived contracting factors (Rubanyi and Vanhoutte, 1985). Various 
endothelium-derived contracting factors have been identified, and include 
endothelin-1, superoxide anions (which act by scavenging nitric oxide), 
endoperoxides and thromboxane A2 (Rubanyi and Vanhoutte, 1986a).
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Physical factors such as pressure and stretch stimulate the release of these 
substances, which also provide local regulation of vascular tone. Pathological states 
such as pre-eclampsia, which result in increased vascular tone and systemic blood 
pressure, may result from an imbalance between the production of endogenous 
vasodilators and vasoconstrictors.
Endothelin-1 (ET-1)
Endothelin-1 (ET-1) is one of the most potent endogenous vasoconstrictor 
polypeptides known, primarily synthesised and released by the vascular 
endothelium. It is a 21 amino acid peptide formed from a larger inactive 38 amino 
acid precursor, bigET-1, by enzymatic cleavage via the metalloprotease endothelin- 
converting enzyme-1 (ECE-1) (Webb, 1997). ET-1 is preferentially and 
predominantly released from the vascular endothelium, and has a major role in the 
regulation of vascular tone. The binding of ET-1 to its receptor is facilitated by a 
family of guanine nucleotide regulatory proteins, or G proteins (heterotrimeric 
proteins comprised of distinct a, p and y subunits) (Warner et a l, 1989; Douglas et 
al, 1995). The altered G protein then reacts with either an enzyme or an ion 
channel evoking appropriate responses within the cell.
There are two different receptors, ETa and ETb, to which ET-1 has binding 
affinities. ETa receptors are found on the external surface of the vascular smooth 
muscle cell (Lüscher et a l, 1993), while ETb receptors are predominantly found on 
the luminal surface of the endothelial cell, but may also preside in the vascular 
smooth muscle cell in some vascular beds (Clozel et a l, 1992). Functional data
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suggests that two sub-types of the ETb receptor exist, an ETbi receptor that 
mediates vasorelaxation via endothelium-dependent nitric oxide release, and an 
ETb2 receptor responsible for mediating peptide-induced smooth muscle 
vasoconstriction (Warner et a l, 1989; Douglas et a l, 1995). Upon its synthesis and 
release from the vascular endothelium, ET-1 exerts an autocrine effect resulting in a 
transient vasodilatation mediated by endothelial ETbi receptors. It also exerts a 
paracrine effect on adjacent vascular smooth muscle cells evoking a slower but 
more sustained contraction via both ETa and ETb2 receptors (Fig. 1.2).
bigET-1
enzyme-1 (ECE-1)
^  Endothelin- converting
ET-1
ETbi Endothelial cell
ETa I  I  E T m r    ...............Vascular smooth
muscle cell1 i
Vasoconstriction Vasorelaxation via
nitric oxide release
Fig. 1.2 The role of endothelin-1 (ET-1) in vascular reactivity.
Classically, the ET-1 ligand-receptor complex has been viewed as a modulator of 
vascular smooth muscle tone and mitogenesis, but is also known to alter smooth 
muscle function in non-cardiovascular tissues such as the respiratory, 
gastrointestinal and urogenital tracts (Bobik et a l, 1990; Douglas and Ohlstein,
1997). An understanding of its contribution to and importance in pregnancy
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appears to be increasing, and is now thought to be involved in the modulation of 
placental blood flow, nonnal feto-placental development and in the pathogenesis of 
various pregnancy-related conditions, such as pre-eclampsia (Sabry et a l, 1995; 
Kohnen et al, 1997; Kurihara et a l, 1994; Clouthier et a l, 1998).
In order to characterise the mechanisms at work in the regulation of vascular tone in 
any single experimental condition, it is often necessary to have a measure of both 
endothelium-dependent and endothelium-independent (and therefore smooth 
muscle-specific) effects. The analysis of independent smooth muscle function in 
conjunction with an analysis of endothelial function is necessary, so that a reliable 
interpretation of endothelial dysfunction will only be made if the underlying smooth 
muscle function is shown to be nonnal. Independent smooth muscle responses can 
be achieved by exposing the vessels to endothelium-independent agonists such as 
the nitric oxide donor, sodium nitroprusside.
1.3 V ascular function in diabetes
The endothelium controls vascular tone by synthesising and releasing various 
vasoconstrictors and vasodilators. It is likely that alterations in the synthesis of 
these endogenous endothelium-dependent factors may contribute to modifications 
in resting vascular tone and the ability of the vessels to respond rapidly to changes 
in metabolic requirements. This may underlie many of the complications 
commonly seen in conditions such as pregnancy-induced hypertension, diabetes.
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cardiac and renal disease (Greer et al., 1991; Greer et a l, 1985b; Wolff et a l, 1997; 
Maguire et a l, 1998; Thambyrajah et a l, 2000; Tomita et a l, 1989).
The effect of diabetes on vascular function appears to be a complex one, depending 
on the species and vascular bed studied. Numerous studies have provided evidence 
for impaired endothelium-dependent vasodilatation in patients with type 1 diabetes 
(Johnstone et a l, 1993; McNally et a l, 1994) and animal models with both genetic 
and chemically-induced type 1 diabetes mellitus (Tesfamariam and Cohen, 1992; 
Heygate et a l, 1995). However, others have also been able to demonstrate normal 
(McIntyre et a l, 2001; Smits et a l, 1993) and even enhanced (White and Carrier, 
1986; Bhardwaj and Moore, 1988) vasodilatation. The importance of disease 
progression has been illustrated by one study carried out by a single investigator 
showing a triphasic response of increased, unaltered and impaired endothelium- 
dependent relaxation within the same model (Pieper, 1999). Although the 
interpretation of studies carried out on animal models cannot be directly transposed 
to humans, they provide a very important contribution to the understanding of 
diabetic pathophysiology.
Endothelium-independent vasorelaxation (ie. smooth muscle function) also appears 
to differ between different study populations, possibly either due to disease 
progression or to experimental methodology. Studies have shown both normal and 
reduced relaxation following exposure to sodium nitroprusside in patients with type 
1 diabetes mellitus (McNally et a l, 1994; Calver et a l, 1992).
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1.3.1 Factors influencing vascular function in diabetes
Although vascular function in diabetes can produce diverse observations, it is the 
impairment of endothelium-dependent vasodilatation that has been most implicated 
in the development of micro-angiopathy. Endothelial damage in diabetes arises 
from the increased likelihood of attack by the metabolic ‘by-products’ of diabetes 
(Poston, 1997). The mechanisms thought to be involved in the development of 
endothelial dysfunction in these patients include -a  reduced synthesis or enhanced 
inactivation of the endothelium-derived relaxing factors; impaired diffusion of the 
relaxing factor to the underlying vascular smooth muscle; reduced sensitivity of the 
smooth muscle to the relaxing factor; or enhanced synthesis and release of 
endothelium-derived constricting factors (De Vriese et a l, 2000). However, it is 
more likely that a combination of these different mechanisms, rather than a single 
factor, accounts for the observable changes in vascular function. Numerous factors 
have been implicated as important determinants of vascular function, and include 
the age at diagnosis and duration of diabetes, the level of metabolic control, and the 
co-existence of lipid abnormalities.
Age o f onset and disease duration
Several studies have shown a strong association between time-related risk variables, 
such as age at diagnosis and duration of diabetes, and the prevalence of diabetic 
complications (The EURODIAB IDDM Complications Study Group, 1994; 
Knuiman et a l, 1986). The onset of type 1 diabetes tends to occur at a younger age 
(compared to the other subtypes of diabetes), and patients therefore have a
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relatively longer duration of disease, increasing the likelihood of micro-angiopathic 
sequelae in later life. A cross-sectional study carried out by Knuiman et al. on 179 
insulin-dependent diabetics showed that age was the single most important time- 
related variable for the development of nephropathy, while both age at diagnosis 
and the duration of diabetes were significant risk factors for developing retinopathy 
and sensory neuropathy (Knuiman et al, 1986). They reported that a 10-year 
increase in disease duration increased the prevalence of retinopathy by -20%, while 
a 15-year increase in the duration of diabetes increased the prevalence to -42%. 
Other significant risk factors for severe retinopathy and nephropathy include 
evidence of other micro-vascular damage, such as albuminuria and hypertension.
Level o f glycaemic control
Hyperglycaemia, although not the only factor involved in the development of 
endothelial dysfunction, plays an important role in the pathogenesis of diabetic 
complications. Sustained episodes of hyperglycaemia resulting from chronic and 
poorly controlled diabetes can induce acute changes in intracellular metabolism and 
lead to the generation of oxygen-derived free radicals, which result in longer-term 
endothelial damage either by inactivating nitric oxide or by acting as 
vasoconstrictors (Rubanyi and Vanhoutte, 1986a; Katusic and Vanhoutte, 1989).
One of the most damaging aspects of chronic poorly controlled diabetes is the 
accelerated synthesis of advanced glycosylation end products (AGEs), formed by 
the non-enzymatic reaction between glucose and collagen (Brownlee et a l, 1988). 
AGEs reduce nitric oxide availability and impair endothelium-dependent relaxation
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in experimental diabetes through the ‘quenching’ of nitric oxide (Bucala et al, 
1991). They also increase the susceptibility of low-density lipoproteins (LDLs) to 
free radical attack, promoting the formation of the oxidised LDLs, which are known 
to cause endothelial damage, inactivate nitric oxide and reduce nitric oxide 
synthesis (Schmidt er , 1991; Schmidt era/., 1990).
Studies have examined the extent to which improved glycaemic control prevents the 
incidence or progression of retinopathy. One such study was a randomised 
controlled trial of strict versus conventional diabetic control (DCCT Research 
Group, 1990). This showed that strict control substantially reduced the risk of long­
term diabetic complications, particularly retinopathy. The EURODIAB IDDM 
Complications Study also reported a decline in the frequency of background 
retinopathy and a coincident rise in proliferative retinopathy when glycosylated 
haemoglobin (HbAic) levels rose above 8%, which agreed with observations by 
Knuiman et a l, and Pirart (The EURODIAB IDDM Complications Study Group, 
1994; Knuiman et a l, 1986; Pirart, 1978).
Plasma lipid profile
Diabetes is a risk factor for atherogenesis and vascular dysfunction related to the 
background population. Studies have demonstrated abnormal lipid patterns, such as 
elevated plasma levels of total and LDL-cholesterol in type 1 diabetics, resulting in 
both impaired endothelium-dependent and -independent vasodilatation (Briones et 
al, 1984; Gibbons, 1986; Harris, 1991; Clarkson et a l, 1996). In fact, 
dyslipidaemia in diabetes has been shown to inactivate endothelial nitric oxide,
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implicating it as one of the possible mechanisms by which vascular damage occurs 
(Bucala et a l, 1991; Schmidt et al, 1991; Schmidt et a l, 1990; Jacobs et a l, 1990).
Hypertriglyceridaemia is often accompanied by a decrease in high-density 
lipoprotein (HDL)-cholesterol, and is the prominent lipoprotein defect in both 
treated and untreated diabetes (Abbate and Brunzell, 1990). Hypertriglyceridaemia 
and raised LDL-cholesterol concentrations are significant risk factors for ischaemic 
heart disease and directly related to serum glucose and HbAic levels (Eckel et al, 
1981).
1.4 C ardiovascular changes in healthy pregnancy
The changes that occur in the cardiovascular system during pregnancy are primarily 
to maintain adequate blood flow through the feto-placental unit, and to compensate 
for the inevitable maternal blood loss at delivery. Cardiac output and plasma 
volume increase by approximately 40% and are associated with vasodilatation in 
the mother to accommodate the increased circulating blood volume. These 
changes, apparent by the second trimester, result in a fall in mean arterial pressure, 
which then increases steadily to reach pre-pregnancy levels at term.
The underlying mechanisms responsible for these vascular changes remain largely 
unclear and unidentified (Pascoal et a l, 1995). One possibility may be alterations 
in signal transduction pathways (Learmont et a l, 1996), which may account for the 
reduction of pressor responses to various vasoconstrictor agonists (Nisell et al,
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1985; Gant et a l, 1973). The increased synthesis and release of various 
endothelium-dependent relaxing factors, such as nitric oxide and prostacyclin 
(Williams et a l, 1997; Greer et a l, 1985a), a reduction in the number of adrenergic 
receptors or a blunting of reflex cardiac responses (Fallgren et a l, 1988; Hart et al, 
1986) have also been implicated.
Studies have demonstrated the importance of nitric oxide in pregnancy, contributing 
substantially to increased peripheral vasodilatation (Williams et a l, 1997; Anumba 
et a l, 1999). McCarthy et a l also observed a moderate to substantial contribution 
of nitric oxide (-30%) to endothelium-dependent relaxation in healthy pregnant 
women (McCarthy et a l, 1994). Along with receptor-mediated responses, flow- 
induced shear stress both in the resistance vasculature and feto-placental circulation 
has also been shown to stimulate nitric oxide release (Kublickiene et a l, 1997; 
Myatt et a l, 1991). Using animal models, others have also demonstrated a 
significantly greater contribution of endothelial hyperpolarization to vascular 
relaxation in pregnant compared to non-pregnant rats (Gerber et al., 1998; Dalle 
Lucca et a l, 2000).
The sensitivity of the smooth muscle to nitric oxide appears to remain unaltered in 
pregnancy, as vascular responses to sodium nitroprusside (nitric oxide donor) have 
been shown to be similar in both pregnant and non-pregnant women (McCarthy et 
al, 1994; Knock and Poston, 1996). This suggests that changes in vascular 
reactivity in pregnancy are more likely to be due to alterations in endothelial rather 
than smooth muscle function.
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1.5 Type 1 diabetes superim posed on pregnancy
In 1989, the St. Vincent Declaration stated ‘VAe outcome o f diabetic pregnancy 
should approximate that o f the non-diabetic pregnane^ (WHO, 1990). However, 
despite significant advances in obstetric and midwifery care, adverse pregnancy 
outcomes continue to remain more common in diabetic compared to non-diabetic 
women, with an increase in the prevalence of pregnancy-induced hypertension, 
congenital anomalies, macrosomia and the increased risk of shoulder dystocia, 
polyhydramnios and sudden fetal death.
The 1994-1996 Report on Confidential Enquiries into Maternal Deaths in the 
United Kingdom reported 2 indirect maternal deaths from diabetes mellitus and 2 
fortuitous late deaths from diabetic ketoacidosis (HMSO, 1998). The 6^  ^Annual 
Report (1996-1997) of the Confidential Enquiry into Stillbirths and Deaths in 
Infancy (CESDI) recorded 16 deaths in the offspring of diabetic mothers, and 18 
deaths in the offspring of women with gestational diabetes (DOH, 1998). In 
Scotland, a national audit was carried out in 22 consultant-led maternity units 
between 1998-1999 aimed at assessing maternity care for women with type 1 
diabetes (Penney and Pearson, 2000). Data from 268 pregnancies were collated and 
of those, 209 pregnancies progressed to delivery while 59 ended in either 
miscarriage or abortion. The perinatal mortality rate was 4/212 (19/1000), which 
resulted from two stillbirths and two neonatal deaths. A total of 19 fetuses were 
identified as having a congenital anomaly (such as sacral agenesis, extra digit, 
ambiguous genitalia, ventricular septal defect) and of those, 6 were aborted.
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The vascular changes associated with type 1 diabetic patients may be further 
amplified during pregnancy, when physiological changes within the cardiovascular 
system occur. It is these alterations in vessel function at the level of the resistance 
vasculature, which are thought to underlie some of the associated complications of 
diabetic pregnancies (Roberts and Redman, 1993; McCarthy et a l, 1993).
1.5.1 Alterations in plasma lipid levels in diabetic pregnancies
Plasma cholesterol and triglyceride levels vary with age, pregnancy and the onset of 
the menopause, with the increase in triglyceride concentrations being primarily due 
to an increase in very low-density lipoprotein (VLDL) concentrations (Stevenson et 
al, 1993; Potter and Nestel, 1979; Sattar and Greer, 1999). The literature suggests 
that mean high-density lipoprotein (HDL) cholesterol levels peak at 28 weeks 
gestation, and are significantly higher in pregnant compared to the non-pregnant 
women (Sattar et a l, 1996). These changes are thought to be associated with 
elevated oestrogen levels in pregnancy, which promote the hepatic synthesis of 
HDL-cholesterol and reduce hepatic lipase activity (Sattar and Greer, 1999; Desoye 
et a l, 1987), and are necessary in meeting the metabolic demands of the fetus and 
preparing the expectant mother for lactation.
The alterations in the plasma lipid profile observed during pregnancy may be 
further exacerbated in the presence of diabetes, which itself exhibits lipid 
abnormalities (Merzouk et a l, 2000; Harris, 1991; Gibbons, 1986). It is possible 
that some of the complications associated with diabetic pregnancies may be due to 
endothelial damage secondary to dyslipidaemia.
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1.6 The effect o f insulin on vascular function
During the course of nonnal human pregnancy, alterations in maternal metabolism 
result from elevated levels of human placental lactogen (hPL), oestrogen, 
progesterone, cortisol and prolactin. Of these, cortisol and hPL in particular, act as 
physiological insulin antagonists and cause a compensatory rise in plasma insulin 
levels and a state of maternal ‘physiological insulin resistance’ (De Swiet, 1996). 
The consequent hyperinsulinaemia contributes to the control of maternal 
euglycaemia and the level of circulating glucose to the developing fetus. In 
normotensive women, fasting levels of insulin in the third trimester of pregnancy 
have been reported to reach 114pM (Martinez et a l, 1998), compared to non­
pregnant levels of 40pM (Kazumi et al., 1999).
1.6.1 Insulin-mediated vasodilatation
Insulin is one of the principle hormones involved in the regulation of plasma 
glucose required for cell metabolism. It is a polypeptide synthesised from an 
inactive precursor, proinsulin, and stored within the p-cells of the pancreas. Along 
with its metabolic effects, insulin is also known to be a vasodilator, and have both 
renal and sympathetic actions (McNally et al, 1995; DeFronzo et a l, 1975; Rowe 
é ta l, 1981).
The majority of the available literature suggests that insulin-mediated 
vasorelaxation is via the activation of nitric oxide synthase and the subsequent 
release of endothelial nitric oxide (Trovati et a l, 1999; Chen and Messina, 1996).
26
However, the vascular effects of insulin have been shown to act not only via the 
endothelium, but the smooth muscle as well, involving several other mechanisms 
such as activation of the Na^/K^ pump via Na^/K^-ATPase (Ferrannini et a l, 1988), 
a reduction in Na"^  permeability compared to penneability (Williams, 1970), 
and/or by a non-specific p-adrenergic mechanism (Creager et al., 1985). It is also 
possible that this may be secondary to either a direct or indirect action on Ca^ -^ 
ATPase resulting in a reduction in intracellular calcium and vasorelaxation (Zemel 
et a l, 1992). These mechanisms result in the in vivo modulation of vascular tone, 
and can be observed in vitro as an attenuation of vasoconstriction to a variety of 
vasoconstrictor agonists (McNally et al., 1995; Yagi et a l, 1988).
The effects of insulin have been shown to be complex and variable in nature 
depending on the state of insulin resistance and vascular bed studied, with a reduced 
effect seen in obese men (Laakso et al., 1990) and patients with non-insulin- 
dependent diabetes mellitus (Laakso et al., 1992). The vascular effects of insulin 
may therefore play an important role in human pregnancy, and an even more critical 
role in diabetic pregnancies, where alterations to both the vasodilatory and 
vasoconstrictive capacity of the endothelium are thought to exist.
Abnormal vascular function has been observed in pathological conditions 
associated with insulin resistance and longer-tenn angiopathic sequelae (Laakso et 
al, 1990; Laakso et a l, 1992; Morris et a l, 1995). However, similar alterations in 
vascular function have not been demonstrated in physiological insulin resistant 
states such as pregnancy, which is not known to be associated with the increased 
risk of small vessel disease (McCarthy et a l, 1994; Ashworth et a l, 1996).
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1.6.2 Other effects of insulin on the vasculature
Along with being able to mediate vasodilatation through nitric oxide synthesis or by 
stimulating smooth muscle directly, recent evidence also suggests that 
hyperinsulinamia accompanying insulin resistance may stimulate the endothelial 
production and secretion of endothelin-1 (Mather et a i, 2001; Frank et a i, 1993; 
Hu et a l, 1993). The interaction between the vasodilatory effect of insulin and its 
ability to stimulate endothelin-1 release may be of greater importance in pregnancy, 
when there is an overall reduction in peripheral vascular resistance. The ultimate 
balance between vasodilator and vasoconstrictor production is critical in 
maintaining vascular function, and it may be this imbalance that contributes to the 
higher incidence of problems observed in pregnant women with diabetes.
1.7 Potential therapies to im prove endothelial function
Over the last few years, research has begun to focus on strategies aimed at either 
retarding or reversing the development of small vessel disease. The aim is to 
reduce the incidence of morbidity and mortality associated diabetes, hypertension 
and hypercholesterolaemia, which have significant implications on health care.
1.7.1 Tight glycaemic control
As mentioned previously, hyperglycaemia increases the production of free radicals 
and advanced glycosylation end products, which either reduce the availability of
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nitric oxide or inactivate it (Rubanyi and Vanhoutte, 1986a; Bucala et al, 1991; 
Schmidt et a l, 1991; Schmidt et a l, 1990). Maintaining good glycaemic control in 
patients with diabetes, reduces the risk of acute and potentially life-threatening 
conditions such as diabetic ketoacidosis and hypoglycaemic coma, as well as 
longer-tenn micro-angiopathic sequelae (retinopathy, nephropathy and neuropathy). 
Achieving steady plasma glucose levels prior to conception and during the period of 
organogenesis (first trimester of pregnancy) reduces the production of free radicals, 
the subsequent risk of congenital malfonnations and the resulting perinatal 
morbidity and mortality. This can be achieved by the administration of insulin, oral 
hypogiycaemics or dietary modification, depending on the type of diabetes and the 
underlying pathology.
1.7.2 Folate
Folate has been shown by various studies to restore endothelial function in patients 
with familial hypercholesterolaemia, as well as healthy volunteers during a 
methionine load test (Usui et a l, 1999; Verhaar et a l, 1999a). Its effects may 
therefore also possibly extend to endothelial dysfunction in diabetes. The use of 
folic acid prior to conception and during early pregnancy has been shown to reduce 
the incidence of neural tube defects (Czeizel and Dudas, 1992), and is now a routine 
part of pre-natal and ante-natal care. The benefits of folate administration may 
therefore be two-fold in pregnant women with diabetes.
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1.7.3 Antioxidants (Vitamins C and E)
The role of antioxidants in the treatment of vascular dysfunction is to decrease the 
production and release of oxygen-derived free radicals. Administration of Vitamin 
C was shown to restore impaired endothelium-dependent vasodilatation in the 
forearm resistance vessels of patients with type 1 diabetes mellitus (Timimi et a l,
1998), and reduce the incidence of congenital malformations in the offspring of 
streptozotocin-induced diabetic rats, supporting the theory that reactive oxygen 
species may be involved in embryonic dysmorphogenesis (Siman and Eriksson,
1997). Vitamin E supplementation has also been shown to partly reduce the 
detrimental effects of increased oxidative stress in diabetic pregnant rats and their 
offspring (Kinalski et a i, 1998). The administration of vitamin supplements is 
already a part of antenatal care and may also serve to improve endothelial cell 
function in humans.
1.7.4 Dihydropyridine calcium channel blockers
Nifedipine, commonly used to treat pregnancy-induced hypertension, has been 
shown to improve endothelial function in patients with hypercholesterolaemia, 
possibly due to a reduction in nitric oxide degradation (Verhaar et al, 1999b). 
However, its role in nonnotensive pregnancies may be limited, given the associated 
physiological fall in blood pressure.
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1.8 Summary
This chapter discusses the importance of the endothelium in resistance arteries 
during pregnancy. The co-existence of diabetes may further contribute to changes 
in vascular responses to endogenous endothelium-dependent vasodilators and 
vasoconstrictors. The literature suggests that endothelial function in patients with 
type 1 diabetes may depend on disease duration and the level of glycaemic control. 
The varying effects of diabetes on the different vascular beds, in tenns of both 
vessel size and location, may reflect the complexity of disease development.
Despite previous extensive investigations of vascular function in patients with 
diabetes, there are few published data on the effect of type 1 diabetes on the 
maternal resistance vasculature in humans. A greater understanding of the role of 
factors involved in the control vascular tone is crucial in both healthy and diabetic 
pregnancies, as they are thought to be significantly altered compared to age and sex- 
matched non-pregnant control subjects. Although recent research has focused on 
therapeutic interventions aimed at either restoring or arresting endothelial 
dysfunction, an initial understanding of these vascular changes must be achieved if 
our aim is to reduce the risk of endothelial damage and the increased incidence of 
complications in this group of women.
1.8.1 Aims and Hypotheses
This thesis concentrates on vascular function in pregnant women with type 1 
diabetes, primarily because of the significant maternal and fetal morbidity and
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mortality associated with the disease, and the limited amount of published literature 
on the subject. The aims of this thesis were, therefore, to study the factors 
controlling vascular reactivity in isolated subcutaneous resistance arteries obtained 
from pregnant women with diabetes. The control of vascular function is multi­
factorial, and the mechanisms most likely to be important were studied.
The hypotheses were:
(i) The vasodilatory effect of insulin is maintained during pregnancy through the 
release of endothelial nitric oxide.
(ii) Pregnant women with diabetes have abnormal vascular function, which may 
contribute to the increased incidence of pregnancy-related complications.
(iii) Endothelium-dependent hyperpolarization contributes significantly to the 
control of vascular function in diabetic pregnant women.
(iv) The vascular effects of endothelin-1 differ in pregnant women with and 
without diabetes.
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Chapter Two
Experimental Methodology
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2.1 Study Groups
Three teaching hospitals within the North Glasgow Hospitals University and 
Yorkhill NHS Trusts were involved in the study. Local Ethical Committee 
approval was granted, and the study was carried out in accordance with the 
Declaration of Helsinki (1996) of the World Medical Association (WMA, 1996). 
All patients were voluntarily recruited, provided with patient information sheets and 
written informed consent obtained.
Three groups of women were studied -  a) type 1 diabetic pregnant women, b) non­
diabetic pregnant women, and c) non-diabetic non-pregnant women. All type 1 
diabetic women were recruited from joint diabetic/ante-natal clinics at the Glasgow 
Royal Maternity Hospital and The Queen Mother’s Hospital. The non-diabetic 
pregnant women were recruited on admission either to the Glasgow Royal 
Maternity Hospital or The Queen Mother’s Hospital, while the non-pregnant 
women were recruited from the Gynaecology ward at the Western Infirmary.
All pregnant women had caesarean sections at term, which, in the diabetic women, 
were carried out as either elective or emergency procedures, but were all performed 
electively in the non-diabetic women. The non-pregnant women were recruited 
from elective gynaecology operating lists for non-malignant conditions, and seen on 
admission to hospital. There were strict inclusion/exclusion criteria for recruitment, 
and this is briefly as follows;
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Pregnant women
• Caesarean section at term
• Fit and well -  no pregnancy related complications such as hypertension and
proteinuria
• No regular medication other than insulin in the diabetic group
• Singleton fetus
• Body mass index of less than thirty
Non-pregnant women
Elective laparotomy for non-malignant conditions 
Under 45 years of age
Regular menstruation with no peri-menopausal symptoms
Fit and well
No regular medication
Body mass index of less than thirty
2.2 Patient Characteristics
A total of 31 diabetic pregnant, 49 healthy pregnant and 23 healthy non-pregnant 
women were recruited over the course of 18 months. As previously mentioned, all 
patients were healthy and not on any regular medication, except the type 1 diabetic 
pregnant women who were maintained on insulin before and during the course of
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their pregnancies. The smoking habits of all patients were recorded to ensure that 
vessel responses could be compared between women that smoked and those that did 
not.
Table 2.1 summarises the total number of women recruited (n), their mean ages and 
smoking habits. All other patient characteristics are described in the individual 
chapters.
Table 2.1 Basic characteristics of all women recruited into the study.
Healthy
pregnant
Diabetic
pregnant
Healthy
non-pregnant
n 49 31 23
Mean age (years) 32 ± 1 30 ± 1 35 ±2
Smokers 16 (33%) 0 3 (13%)
Ages are given as mean ± standard error of the mean.
2.3 Sm all vessel w ire m yography
Numerous different techniques have been used to investigate vascular function. In 
vivo methods such as venous occlusion plethysmography, laser Doppler fluximetry 
and laser Doppler perfusion imaging, allow the study of arteries in their 
physiological environment (Johnstone et a l, 1993; Shore et a l, 1991; Jaap et ai,
1995). Laboratory based techniques such as small vessel (McNally et a l, 1994;
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Knock et a l, 1997), large vessel (Kamata et a l, 1989) and perfusion (Tribe et al,
1998) myography have been used to assess vascular function in vitro, and allow 
greater pharmacological manipulation that may not otherwise be possible. This 
thesis examines various factors controlling vascular function in pregnant women 
with type 1 diabetes using conventional small vessel wire myography, a laboratory- 
based organ bath technique.
Before the development of the small vessel myograph, it was impossible to carry 
out functional experimentation of small blood vessels in vitro. The wire myograph 
used in this study is a model developed by Mulvany and Halpem in 1976, based on 
the original 1972 suggestion by Bevan and Osher (Mulvany and Halpem, 1977; 
Bevan and Osher, 1972). The advantage of this technique over in vivo techniques is 
that pharmacological agents that may not be safe or possible in vivo can be safely 
studied, for example, apamin and charybdotoxin, potent toxins which in 
combination allow the in vitro study of the effects of endothelial hyperpolarization 
(Edwards et a l, 1998).
2.3.1 Tissue collection and arterial dissection
At laparotomy, the surgeons involved agreed to obtain the biopsy specimens. Strips 
of subcutaneous fat and skin were obtained from the incision edge unless the patient 
or the surgeon requested that no skin was to be taken, at which point only 
subcutaneous fat was excised. The biopsy was taken along the length of the 
incision as a wedge, measuring approximately 5cm long, 0.5cm wide and 1cm deep, 
allowing the cosmetic appearance of the wound to be maintained. Although the
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vessels studied were subcutaneous and not cutaneous resistance arteries, many of 
the resistance arteries run through the subcutaneous tissue very close to the skin. 
Excising skin and subcutaneous tissue aids vessel identification. The biopsies were 
immediately transported to the laboratory in 0.9% saline in ice and placed into cold 
physiological saline solution (PSS) upon arrival.
The biopsies were divided into two halves to allow easier manipulation of the 
tissue. One half was placed in a petri dish and pinned to hold it in place, and the 
tissue constantly moistened with cold PSS. With the aid of a dissecting light 
microscope (Olympus SZ40®), small arteries (luminal diameter -100-500pm) were 
isolated from the surrounding subcutaneous fat by blunt dissection with fine forceps 
(Agar Scientific®) and Mcpherson-Vannas dissecting scissors (World Precision 
Instruments®). They were identified from their venous counterparts by their 
physical appearances, which included wall thickness, vessel rigidity and vessel 
characteristics at branching points. (The vessels would be confirmed as arterial 
during the ‘normalisation’ process and ‘start-up’ procedure.) Isolated arteries were 
stored in PSS overnight at 4°C. The mean time of storage of the vessels was 15 
hours (range 0-19 hours) prior to experimentation.
The storage of subcutaneous vessels overnight is not thought to affect their pH or 
function, and has been previously shown to be acceptable with no measurable 
change in function observed. McIntyre et a l, showed that vascular function was 
preserved in third order rat mesenteric arteries following cold storage for up to 4 
days, when exposed to the vasoconstrictors -noradrenaline phenylephrine, 
potassium chloride and endothelin, and the vasodilators -acetylcholine and 3-
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morpholinosydnonimine (McIntyre et a l, 1998), In this study, although there did 
not appear to be any difference between vessels experimented on immediately 
following dissection and those stored overnight in terms of vascular relaxation or 
constriction, overnight storage is an important point in the interpretation of this 
dataset. The relationship between storage time, maximal relaxation and 
vasoconstriction is shown in Table 2.2.
Table 2.2 The relationship between vessel storage time and vascular function.
Storage Healthy pregnant 
Time (n-88)
(Hours) Max, Relaxation Tension 
(%) (mN/mm)
Diabetic pregnant 
(n=32)
Max, Relaxation Tension 
(%) (mN/mm)
Healthy non-pregnant 
(n=29)
Max, Relaxation Tension 
(%) (mN/mm)
0 95.4 ± 1 .2 2 .9± 0 .1 98.0 ± 0 .8 4.2 ±0 .5
15 91.2 ± 2 .2 3.8 ±0.3 95.0 ± 0 .9 3.0 ±0.3 91.8 ±4.3 3.7 ±0 .4
19 95.9 + 1.4 3.2 ±0.5 95.4 ±1.5 2.9 ±0.5 99.8 ± 0 .2 3.0 ±0.5
Values are expressed as mean ± standard error of the mean, n, number of vessels 
obtained.
2,3.2 Arterial mounting
Isolated arteries were mounted onto a small vessel wire myograph (Danish 
Myotech®, Aarhus, Denmark) to measure isometric tension (Myodaq/Myodata 
2.01®) using standard methodology (Mulvany and Halpem, 1977). This involved 
threading two 40pm stainless steel wires through the vessel lumen under 
magnification at room temperature (Fig. 2.1). There was very little manipulation of
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the artery with dissecting equipment during the mounting procedure, thereby 
minimising damage to the endothelium and underlying smooth muscle.
Resistance artery 40pm wire
Fig. 2.1 Illustration of a resistance artery clearly showing the two wires through 
its lumen
The wires were secured onto a mounting head, one end of which was attached to a 
micrometer and the other to a force transducer, allowing measurements of isometric 
tension generated by the vessel to be made (Fig. 2.2). The myograph has four sets 
of mounting heads, each sitting within a 5ml organ bath, allowing the responses of 
four vessels to be studied simultaneously under identical conditions.
To micrometer
To force transducer
Fig. 2.2 Illustration of the mounting head of a Mulvany Halpem wire myograph. 
This sits within a 5ml organ bath.
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2.3.3 Normalisation procedure
Once mounted, the vessels were allowed to equilibrate for one hour in PSS at 37°C 
and exposed to a combination of 9 5 %0 2 /5 %C0 2 . This ‘gassing’ mixture was 
required to keep the pH of the PSS at 7.4 when it was heated to 37°C. After this 
period of equilibration, the vessels were ‘normalised’. This process determined 
each individual vessel’s passive length-tension characteristics, and allowed a 
measure of standardisation for each individual vessel and experiment.
The normalisation procedure was performed using an iterative Myodaq/Myodata 
2.01® program written by the myograph manufacturers (Danish Myotech®, 
Aarhus, Denmark). The procedure involved using the micrometer to stretch the 
vessel in a series of steps (2-3mN per stretch) at one-minute intervals. Following 
each stretch, the vessel relaxed to a resting tension. After one minute, the next 
stretch was applied. A one-minute interval per stretch allows the vessel to reach 
approximately 90-95% of the maximum response (increasing this to two-minute 
intervals or longer does not significantly affect the calculation, but merely increases 
the length of the protocol).
The change in tension was noted before (tension 1) and after (tension 2) each 
stretch to allow calculation of wall force:
Wall force (mN) -  (tension 2-tension 1) x transducer sensitivity
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From this and the vessel length (measured previously), the wall tension was 
calculated:
Wall tension (mN/mm) = Wall force/Vessel length
Internal circumference (L) at each point was calculated by:
L = (micro A-micro B) x 2 + internal circumference at B
Where micro A = micrometer reading from that stretch
micro B = micrometer reading with wires touching
Using Laplace’s equation, which relates transmural tension and vessel 
circumference to the transmural pressure, the ‘effective pressure’ was calculated at 
each step:
Pressure = Wall tension/(internaI circumference/2jr)
The stretches were repeated until an effective pressure of lOOmmHg (13.3kPa) was 
reached. The calculated effective pressure is an estimate of the transmural pressure 
that would be needed in vivo to stretch the relaxed vessel to the given internal 
circumference. The program then fitted an exponential curve to the results by 
plotting wall tension against internal circumference for each stretch. This describes 
increasing wall tension for each increase in circumference over the range of the 
normalisation procedure.
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Using Laplace’s law, an isobar was calculated:
Wall tension = (lOOmmHg) x (internal cireumference/27r)
The point where the isobar and the exponential curve crossed represented the 
estimated internal circumference, designated LI00, which this particular vessel 
would have under a transmural pressure of lOOmmHg. The vessels were set to 90% 
of this value (0.9 x L I00), designated L90, which has been shown to be the internal 
circumference at which the vessels will produce a maximum contractile response 
(Mulvany and Halpern, 1977). Although the L90 used in wire myography vessel 
normalisation was originally standardised for rat mesenteric vessels, this level of 
stretch in human resistance arteries is optimal for maximum active mechanical 
output, and has been tested in several laboratories in Glasgow, Edinburgh, Leicester 
and Aarhus (Hillier, personal communication). The nonnalised luminal diameter 
was calculated as:
L90/7t
2.3.4 Tension measurements
Before coimnencing pharmacological experiments, vessel viability (contractile and 
endothelial function) was confirmed by carrying out a ‘start-up’ protocol. This 
involved constricting the vessels using a 123mM potassium chloride solution 
(KPSS), washing them out three times with PSS and allowing relaxation back to the 
baseline. This procedure was repeated three times (Fig 2.3).
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Tension
Time
wash out wash out wash out
plateau is taken as 
the maximum vessel 
contraction to 
123mMKPSS
t
123mMKPSS
t t
123mMKPSS 123mMKPSS
Fig 2.3 A representative trace showing constriction of a resistance artery using 
123mM potassium chloride solution (KPSS).
A test of endothelial function was made by preconstricting the vessels with lOpM 
noradrenaline and observing relaxation to 3pM acetylcholine. In vessels requiring 
endothelial denudation, using a technique described by Osol et al., a human hair 
was washed in ethanol and rinsed in PSS prior to repeated insertion through the 
vessel lumen (Osol et a l, 1989). In these vessels, no relaxation to acetylcholine 
was observed (Fig. 2,4).
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3pM acetylcholine
I
Tension
Time
wash out
t
preconstriction with lOpM 
noradrenaline following 
endothelial denudation
Fig, 2.4 A representative trace demonstrating a lack of relaxation to 
acetylcholine in a denuded resistance artery.
The vessels were then rinsed three times with PSS and allowed to relax to baseline. 
Finally, to provide a measure of maximal vasoconstriction, the vessels were 
constricted with lOpM noradrenaline in 123mM KPSS, rinsed three times with PSS, 
allowed to relax to baseline, and then equilibrated for a further hour (Fig. 2.5),
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wash out
I
Tension
Time
t
preconstriction with 
lOpM noradrenaline in 
123mMKPSS
Fig. 2.5 A representative trace illustrating maximal vasoconstriction following 
exposure to lOpM noradrenaline in 123mM potassium chloride solution 
(KPSS).
2.3.5 Criteria for rejection of vessels
Endothelial function was assessed in all arteries by observing relaxation to 3pM 
acetylcholine following preconstriction with lOpM noradrenaline (Fig. 2.6). 
Arteries that did not achieve at least 60% relaxation were considered to be damaged 
and unsuitable for studies of endothelial function. Mechanical damage in my 
experience usually significantly reduces endothelial relaxation responses to below 
15%. On the other hand, the literature suggests that the observed relaxation to 
acetylcholine in both pregnant and non-pregnant women, and patients with type 1 
diabetes and gestational diabetes, will be approximately equal to or greater than
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60% (McCarthy et a i, 1994; McNally et aL, 1994; Knock et a l, 1997). The use of 
a 60% cut-off therefore ensured that only mechanically damaged vessels would be 
excluded, and functionally impaired (by the disease process) vessels would be 
included. Vessels were also rejected if they did not produce sustainable 
contractions (greater than 3 minutes) to 123mM KPSS or lOpM noradrenaline in 
123mM KPSS. Table 2.3 represents the total number of women from whom 
arteries were successfully dissected (No. of successful biopsies) following 
recruitment, the total number of isolated arteries, and the number of vessels used 
and rejected. There was no difference in the percentage of rejected vessels per 
patient group.
Tension
Time
relaxation to 3pM acetylcholine
I
wash out
t
preconstriction with 
lOpM noradrenaline
Fig. 2.6 A representative trace illustrating acetylcholine-induced relaxation in a 
resistance artery following preconstriction with lOpM noradrenaline.
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Table 2.3 Table summarising the total number of small arteries used in and 
rejected in all experiments.
Healthy
pregnant
Diabetic
pregnant
Healthy
non-pregnant
Total no. of women recruited 49 31 23
No. of successful biopsies 34 (69%) 16 (52%) 19 (83%)
Total no. of vessels obtained 106 39 34
No. of vessels used 8 8  (83%) 32 (82%) 29 (85%)
No. of vessels rejected 18(17%) 7(18%) 5 (15%)
2.4 Pharmacological protocols
1. To investigate the effect of insulin-mediated vasodilatation in pregnant women, 
and the role of nitric oxide in the mediation of this response (Chapter 3).
Three study protocols were used;
Study 1.1 -  Cumulative concentration response curves to noradrenaline (InM to 
30juM) were performed before and following 30 minutes incubation with insulin 
(l.OmU/mL). A third curve was then perfonned in the presence of both insulin 
(l.OmU/mL, 30 minutes) and N®-L-arginine methyl ester (L-NAME O.lmM, 30 
minutes), a competitive inhibitor of nitric oxide synthase.
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Study 1.2 -  To test for an order effect, in a different set of vessels, cumulative 
concentration response curves to noradrenaline (InM to SOjuM) were performed 
before and after incubation with L-NAME (0. ImM, 30 minutes). A third curve 
was then performed in the presence of both L-NAME (O.lmM, 30 minutes) and 
insulin (l.OmU/mL, 30 minutes).
Study 1.3 -  To specifically examine the endothelium-dependent effect of 
insulin in pregnant women, cumulative concentration response curves to 
noradrenaline (InM to SOpM) were performed, before and after 30 minutes 
incubation with insulin (l.OmU/mL), following endothelial denudation.
2. To investigate the contribution of each endothelium-dependent relaxing factor 
to vasorelaxation in pregnant women with and without type 1 diabetes (Chapter 
4).
Three experimental protocols were used:
Study 2.1 -  Cumulative concentration response curves were performed to 
carbachol (InM to 30|uM) following vessel preconstriction with lOjuM 
noradrenaline. Three subsequent curves were then performed following a 30- 
minute incubation with:
a) N®-nitro-L-arginine methyl ester (nitric oxide synthase inhibitor, L-NAME 
O.lmM)
b) L-NAME and indomethacin (cyclo-oxygenase inhibitor, INDO SOpM)
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c) L-NAME, indomethacin and 25mM potassium chloride solution (inhibitor 
of endothelial hyperpolarization) (Gerber et a l, 1998)
Study 2.2 -  To ensure that residual relaxation following nitric oxide synthase 
inhibition was not due to an incomplete inhibition of the pathway, the vessels 
were incubated for 30 minutes with L-NAME (O.lmM), indomethacin (30qM) 
and oxadiazoloquinoxalin (ODQ IpM), an inhibitor of soluble guanylate 
cyclase.
Study 2.3 -  To confirm the contribution of endothelial hyperpolarization to the 
residual relaxation response following inhibition of nitric oxide synthase and 
cyclo-oxygenase. Carbachol and sodium nitroprusside studies were repeated 
following 30 minutes incubation with charybdotoxin (lOOnM) and apamin 
(lOOnM), inhibiting both large and small conductance calcium-dependent 
potassium channels and the endothelium-dependent hyperpolarization (Zygmunt 
et a l, 1997; Edwards et a l, 1998).
To study the effectiveness of cAMP and cGMP pathways in the vascular smooth 
muscle, independent of endothelial modulation (Chapter 4).
Study 2.4 -  Cumulative concentration response curves were performed to 
prostacyclin (InM to 30|uM) and sodium nitroprusside (InM to 30pM), 
endothelium-independent agonists dependent on cAMP and cGMP respectively.
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3. To investigate the vasoconstrictor response to noradrenaline and endothelin-1 
(ET-1) in resistance arteries obtained from pregnant women with type 1 
diabetes mellitus (Chapter 5).
Two study protocols were used:
Study 3.1 -  Cumulative concentration response curves to noradrenaline (InM to 
30|liM) were performed.
Study 3.2 -  Cumulative concentration response curves were performed using 
ET-1 (lpMto0.3pM).
2.5 Drugs and solutions
All drugs, obtained from Sigma, Poole, UK and CN Biosciences, Nottingham, UK, 
were made up with either distilled water or dimethyl sulphoxide (DMSO).
The following drugs were dissolved in distilled water:
Noradrenaline, N®-nitro-L-arginine methyl ester (L-NAME), Insulin, Carbachol, 
oxadiazoloquinoxalin (ODQ), Apamin, Charybdotoxin, Sodium nitroprusside. 
Prostacyclin, Endothelin-1.
Indomethacin was dissolved in dimethyl sulphoxide (DMSO).
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PSS had the following composition: NaCl 118mM, NaHCOs 25mM, KCl 4.5mM, 
KH2PO4 l.OmM, CaCL 2.5mM, MgSO^ l.OmM and CgHiiOg (D-glucose) 6.0mM, 
0.023mM EDTA and 0.03mM ascorbic acid. 25mM and 123mM KPSS had similar 
compositions to physiological saline, and were made by substituting NaCl for KCl 
on an equimolar basis.
The concentration of inhibitor drugs used are the standard concentrations known to 
inhibit the corresponding agonist, while the concentrations of agonists used are the 
ranges known to demonstrate a dose-dependent effect on vascular responses 
(McNally et a l, 1995; Gerber et a l, 1998; Edwards et a l, 1998; McIntyre et a l, 
2001). The concentration of insulin used was chosen purely on a phannacological 
basis. It has been previously shown that this particular concentration of insulin is 
able to demonstrate the greatest attenuation of the noradrenaline response (McNally 
e ta l,  1995).
Carbachol rather that acetylcholine was used to study endothelium-dependent 
relaxation, as this is the standard endothelium-dependent muscarinic agonist used in 
our laboratory. It is a non-selective agonist that is resistant to the action of 
cholinesterases.
2.6 Data representation
Contractile responses are expressed as a percentage of the maximum potassium 
contraction for each individual vessel (%K"^ ), allowing for the standardisation of
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responses between vessels. Relaxation responses are expressed as a percentage of 
the maximum tension generated following arterial pre-constriction with lOpM 
noradrenaline, allowing all vessel responses to be standardised.
The number of experiments is represented as n(N), where n is the number of vessels 
obtained and N the number of patients recruited.
2.7 Statistical analysis
Maximmn contraction and relaxation were compared using either Student’s t test, or 
a one-way ANOVA and Bonferroni’s post hoc test for multiple comparisons. For 
the analysis of the cumulative concentration response curves, a one-way ANOVA 
for repeated measures was used, which took the ‘non-independence’ of the 
individual concentrations used into account (ie. each response is dependent on the 
previous response). Sensitivity is expressed as the pDz, which is the negative log of 
the concentration required to produce 50% of the maximum response. The actual 
statistical test used for each experiment is reported in the appropriate chapter. A p 
value <0.05 was accepted as being statistically significant.
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Chapter Three
Insulin-Mediated Vasorelaxation in Pregnancy
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3.1 Introduction
Insulin is one of the few hormones that can demonstrate diverse effects, ranging 
from metabolic, biological and genetic influences, to mitogenesis and ion transport 
(Rosen, 1987; O’Brien and Granner, 1991; Moore, 1983). It can also act directly on 
the vasculature, and has been shown to have vasodilatory properties (Scherrer et al, 
1994; Steinberg et a l, 1994; Creager et a l, 1985). The mechanisms of action 
underlying insulin-mediated dilatation vary depending on the subject and tissue type 
studied, and include release of nitric oxide from the vascular endothelium, 
activation of the Na^/K^ pump on the plasma membrane, and a non-specific (3- 
adrenergic mechanism (Scherrer et a l, 1994; Prakash et a l, 1992; Creager et a l, 
1985). Studies have demonstrated a reduction in insulin-mediated vasorelaxation in 
insulin-resistant states such as obesity, type 2 diabetes and hypertension (Laakso et 
al, 1990; Laakso et a l, 1992; Baron et a l, 1993). It has been suggested that the 
resulting decrease in vascular perfusion may contribute to the insulin resistance 
observed in these patient groups.
The changes in hormonal profile and carbohydrate metabolism during pregnancy 
result in physiological insulin resistance and hyperinsulinaemia, with plasma insulin 
levels trebling to maintain maternal and fetal euglycaemia. As the levels of insulin 
increase substantially during pregnancy, insulin-mediated vasodilatation may be an 
important factor in the control of vascular tone.
In Chapter 1, the importance of the resistance vasculature in the control of blood 
pressure and tissue perfusion was described. Disturbances in vascular reactivity
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may result from pathologically insulin resistant states, but are unlikely to be present 
in physiological insulin resistance, since pregnancy per se is not associated with the 
development of micro-vascular disease. One possible explanation for this is that 
insulin resistance in pregnancy develops more acutely with a shorter duration of 
action followed by resolution post-partum.
This chapter investigates the effect of insulin-mediated vasodilatation in healthy 
pregnant women, and the role of nitric oxide in the mediation of this response. It 
was hypothesised that the vasodilatory effect of insulin is maintained in pregnancy 
through the release of endothelial nitric oxide.
3.2 Methods
3.2.1 Study groups
Local Ethical Committee approval was granted. Fourteen pregnant and seven non­
pregnant women were recruited into the study and written informed consent 
obtained. All the patients were healthy, not on any regular medication and had no 
history of diabetes or hypertension. Blood pressure was checked prior to surgery on 
all women upon admission. The pregnant women underwent elective caesarean 
section at term (seven for breech presentation and seven for previous section), and 
the non-pregnant women underwent elective gynaecological surgery. Table 3.1 
summarises the patient ages, blood pressures (BP) and smoking habits, and the 
mean luminal diameter of isolated arteries.
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Table 3.1 Characteristics of patients recruited into the study investigating insulin- 
mediated vasodilatation in isolated small arteries.
Healthy pregnant Healthy non-pregnant Significance
Age (years) 31 ±1 33+3 NS
Internal diameter (pm) 273 ± 18 274 + 17 NS
Blood pressure (systolic) (mmHg) 114 + 4 120 + 5 NS
Blood pressure (diastolic) (mmHg) 70 + 3 68 ±3 NS
Smokers 1/14 2/7 -
Values are expressed as mean ± standard error of the mean. Significance accepted 
if p<0.05. Student’s t test. NS^ not significant.
3.2.2 Experimental protocols
The standard methodology of small vessel wire myography has been explained in 
detail in Chapter 2. Only protocols and solutions specific to this chapter have been 
described here.
Following the dissection of the biopsies, the vessels were tested for viability and 
endothelial function. The arteries obtained from pregnant women achieved a mean 
relaxation of 75.0 ± 2.6%, while vessels from the non-pregnant women achieved 
76.0 ± 2.8% relaxation.
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3.2.3 Pharmacological protocols
Three pharmacological protocols were used:
Study 1 -  Cumulative response curves to noradrenaline (InM to 30pM) were 
performed before and following 30 minutes incubation with insulin (l.OmU/mL) 
(McNally et aL, 1995). A third curve was then performed in the presence of both 
insulin (l.OmU/mL, 30 minutes) and N®-nitro-L-arginine methyl ester (L-NAME 
0. ImM, 30 minutes), a competitive inhibitor of nitric oxide synthase.
Study 2 -  To test for an order effect, in a different set of vessels, cumulative 
concentration response curves were performed to noradrenaline (InM to 30pM) 
before and after incubation with L-NAME (0. ImM, 30 minutes). A third curve was 
then performed in the presence of both L-NAME (O.lmM, 30 minutes) and insulin 
(l.OmU/mL, 30 minutes).
Study 3 -  To specifically examine the endothelium-dependent effect of insulin in 
pregnant women, cumulative concentration response curves to noradrenaline (InM 
to 30pM) were performed, before and after incubation with insulin (l.OmU/mL, 30 
minutes), following endothelial denudation (Chapter 2). The absence of functioning 
endothelium was confirmed by observing no relaxation to 3pM acetylcholine in 
vessels preconstricted with lOpM noradrenaline.
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Noradrenaline (InM to 30pM)
Ur
Insulin ( 1 .OmU/mL) L-NAME (O.lmM)
4
Insulin (l.OmU/mL) + L-NAME (O.lmM) +
L-NAME (O.lmM) Insulin (l.OmU/mL)
Fig. 3.1 The two pharmacological protocols used to examine the effects of 
noradrenaline, insulin and N®-nitro-L-arginine methyl ester (L-NAME) 
on isolated arteries obtained from both pregnant and non-pregnant 
women.
3.2.4 Drugs and solutions
All drugs were obtained from Sigma, Poole, UK, and made up in distilled H2O. PSS 
and KPSS were made as stated previously in Chapter 2.
3.2.5 Statistical analysis
Contractile responses are expressed as a percentage of each individual vessel’s 
maximum potassium contraction, allowing for the standardisation of responses 
between vessels. Data are expressed as mean ± standard error of the mean (SEM). 
The number of experiments is expressed as n(N), where n is the number of vessels 
and N is the number of patients. Maximum contraction and sensitivity (pD2 -  
negative log of the concentration required to produce 50% of the maximum 
response) were compared using one-way ANOVA and Bonferroni’s post hoc test 
for multiple comparisons. A p value <0.05 was accepted as being statistically 
significant.
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3.3 Results
Results from smokers and non-smokers were combined. Vessel responses were not 
noted to be obviously different (Table 3.2).
Table 3.2 Summary of maximum responses (%K’*) and sensitivity (pDz) to 
noradrenaline in smoking and non-smoking patients.
Healthy pregnant 
Smokers Non-smokers
Healthy non-pregnant 
Smokers Non-smokers
n 1 13 2 5
NA -
Max. Response (%) 105.9 104.5+3.4 110.6+19.4 98.9 ±0.5
pDz 5.7 6,3 +0.1 6.6 +0.3 6.7 ± 0.2
NA+INS
Max. Response (%) 94.7 86 .5+ 7 .0 99.5 + 21.0 88.5 + 9.1
pÜ2 5.7 6.3 ±0.3 6.5 ±0 .3 6.6 ± 0.2
NA+L-N
Max. Response (%) 137.0 147.9 + 15 127.6 ± 12.6 116.0 + 13.8
PÜ2 7.0 7 .2 + 0 .4 6.3 ± 0.1 6.5 ±0 .2
NA+L-N+EVS
Max. Response (%) 115.6 98.5 ± 8.4 128.1 ± 4 .6 101.1 ±11.9
pD2 7.2 7 .4+  0.3 6.3 + 0.1 6.6 ± 0.2
NA+EVS-EIVDO
Max. Response (%) 67.5 58.3 ± 16.6 - -
pDz 6.4 6 .6+  0.2 - -
Values are mean ± SEM. NA, noradrenaline; INS, insulin; L~N, L-NAME; -ENDO, 
without endothelium.
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No differences in the noradrenaline sensitivity (pD]) were observed between the 
two groups as illustrated in Table 3.3.
Table 3.3 Table summarising the vessel sensitivity to noradrenaline (pDi) in 
pregnant and non-pregnant women.
Healthy pregnant 
(pD2>
Healthy non-pregnant 
(Pl>2) Significance
NA 6.27 ±0.14 6 . 6 6  ± 0.16 NS
NA+INS 6.24 ±0.12 6.60 + 0.17 NS
NA+L-N 7.17 ±0.27 6.43 ±0.15 NS
NA+L-N+INS 6.33 ±0.15 6.77 + 0.16 NS
NA+INS-ENDO 6.58 ±0.17 - -
Values are mean ± SEM. Significance assumed if p<0.05. Student’s t test. NS, not 
significant; NA, noradrenaline; INS, insulin; L-N, L-NAME; -ENDO, without 
endothelium.
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(i) Noradrenaline
There was no difference in the maximum vasoconstriction response to 
noradrenaline between vessels obtained from pregnant and non-pregnant women 
[Maximum response (%K^) pregnant 104.6 ± 3.2%, n=17(8) vs. non-pregnant 100.9 
± 6.4%, n=17(8) p>0.05. Fig. 3.2].
K—NA (pregnant)
120 -I •S— NA(non-pregnant)
t 80 •
I
§ 40-
U
-8-9 ■7 6 -5
NA (Log M)
Fig. 3.2 The effect of noradrenaline (NA) on isolated resistance arteries obtained 
from healthy pregnant and non-pregnant women (p>0.05).
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(ii) Insulin
Insulin (INS) caused a significant reduction in the maximum contractile response to 
noradrenaline (NA) in pregnant women. The following figure is an experimental 
trace of a subcutaneous resistance artery obtained from a healthy pregnant women 
subjected to cumulative concentrations of noradrenaline (InM to SOpM), initially 
on its own, and then in the presence of insulin (l.OmU/mL) (Fig. 3.3.1).
Tension
Time
wash out
t
noradrenaline
Incubation with l.OmU/ml insulin
t
noradrenaline
fi 4t
wash out
Fig. 3.3.1 A representative trace of a resistance artery exposed to cumulative 
concentrations of noradrenaline and then repeated following a 30 
minute incubation with l.OmU/mL insulin.
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When expressed as a percentage of the maximum response to 123mM potassium 
chloride solution (KPSS): Maximmu response (%K'*') NA 104.6 ± 3.2%, n=17(8) 
NA + INS 86.7 ± 6 .6 %, n=17(8) *p<0.01, Fig. 3.3.2].
NA (pregnant)
120 n NA+Insulin (pregnant)
9 8 67 ■5
NA (Log M)
Fig. 3.3.2 The effect of insulin on vasoconstriction responses to noradrenaline 
(NA) in subcutaneous small arteries obtained from healthy pregnant 
women at term (*p<0 .0 1 ).
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In the non-pregnant group of women, insulin caused an attenuation of the maximum 
response to noradrenaline by approximately 1 0 %, however, this was not statistically 
significant [Maximum response (%K^ NA 100.9 ± 6.4%, n -ll(7 )  vs. NA + INS
90.5 ± 8.5%, n=l 1(7) p>0.05. Fig. 3.3.3].
120 T
I
H9—NA (non-pregnant)
NA + Insulin (non-pregnant)
- 8  -7 - 6
Log NA (M)
Fig. 3.3.3 The effect of insulin on vasoconstriction responses to noradrenaline 
(NA) in subcutaneous small arteries obtained from healthy non-pregnant 
women (p>0.05).
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(iii) L-NAME
In a different set of vessels obtained from the same patients, incubation with L- 
NAME alone caused a significant potentiation of the maximum contractile response 
to noradrenaline in vessels obtained from pregnant women [Maximum response 
(%K+) NA 118.8 ± 8 .8 %, n=9(5) vs. NA + L-NAME 145.4 + 12.0%, n=9(5) 
*p<0.05. Fig. 3.4.1],
■NA (pregnant) 
•NA+L-NAME (pregnant)
160 1
a
9 -7 -6■8 -5
NA(LogM)
Fig. 3.4.1 The effect of incubation with L-NAME on vasoconstriction responses to 
noradrenaline (NA) in subcutaneous small arteries obtained from 
healthy pregnant women at tenn (*p<0.05).
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No significant potentiation was seen in vessels collected from non-pregnant women 
[Maximum response NA 115.8 ± 8.2%, n=10(7) vs. NA + L-NAME 119.7 ± 
10.5%, n=10(7) p>0.05, Fig. 3.4.2].
■NA (non-pregnant)
160 n -A—NA + L-NAME (non-pregnant)
120 -
I  80-
i
U 40 -
9 6•7-8 ■5
Log NA (M)
Fig. 3.4.2 The effect of incubation L-NAME on vasoconstriction responses to 
noradrenaline (NA) in subcutaneous small arteries obtained from 
healthy non-pregnant women (p>0.05).
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(iv) L-NAME and Insulin
Following incubation with L-NAME, the subsequent addition of insulin resulted in 
significant attenuation of the maximum response in pregnant women.
Figure 3.5.1 is an experimental trace of a subcutaneous resistance artery obtained 
from a healthy pregnant women subjected to cumulative concentrations of 
noradrenaline (InM to 30qM), following incubation with L-NAME and then with 
L-NAME and insulin.
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When expressed as a percentage of the maximum response to 123mM potassium 
chloride solution (KPSS): Maximum response (%K^) NA + L-NAME 145.4 + 
12.0%, n=9(5) NA + L-NAME + INS 97.3 ± 5.5%, n=9(5) *p<0.01, Fig. 3.5.2].
■NA+L-NAME (pregnant) 
■NA+L-NAME+Insulin (pregnant)
160 1
"S'
&
1 2 0 -
I  80-
I
U 40 -
9 -8 -7 6
NA (Log M)
Fig, 3.5.2 The effect of the addition of L-NAME and insulin on vasoconstriction 
responses to noradrenaline (NA) in subcutaneous small arteries obtained 
from healthy pregnant women at term (*p<0 .0 1 ).
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Relaxation was not observed in the non-pregnant women [Maximum response 
(%K’^  NA + L-NAME 119.5 ± 10.5%, n=10(7) vs. NA + L-NAME + INS 108.5 ± 
9.5%, n=10(7) p>0.05. Fig, 3.5,3],
—A NA+L-NAME (non-pregnant)
•NA+L-NAME+Insulin (non-pregnant)
I
§u
160
120
80
40
0
-7 -6-89 ■5
NA (Log M)
Fig. 3.5.3 The effect of the addition of L-NAME and insulin on vasoconstriction 
responses to noradrenaline (NA) in subcutaneous small arteries obtained 
from healthy non-pregnant women (p>0.05).
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(v) Following endothelial denudation
Insulin caused a significant reduction in the maximum contractile response to 
noradrenaline in pregnant women following the removal of the endothelium 
[Maximum response (%K"^ ) NA 95.5 ± 5,5%, n=13(6) v& NA + INS 64.4 ± 8.2%, 
n=13(6) '=^p<0.01,Fig. 3.6].
120 1 ■NA (pregnant)
■ NA+Insulin (pregnant)
I
-8 -7 -6
NA (Log M)
Fig. 3.6 The effect of insulin on vasoconstriction responses to noradrenaline 
(NA) in subcutaneous small arteries obtained from healthy pregnant 
women following endothelial denudation (*p<0 .0 1 ).
72
3.4 Discussion
To my knowledge, this is the first study to demonstrate a significant attenuation of 
noradrenaline-induced tone, following incubation with insulin, in isolated small 
arteries from healthy pregnant women. Furthermore, it demonstrates that in these 
women, the vasodilatory effect of insulin is via an endothelium-independent 
mechanism.
Insulin is able to modulate the vasoconstrictor effect of noradrenaline in pregnancy, 
a situation in which physiological insulin resistance and hyperinsulinaemia develop. 
This observation is important, and along with the in vivo hyperinsulinaemia may 
account for the increased vasodilatation and reduced peripheral vascular resistance 
necessary to maintain blood pressure in the presence of an increased circulating 
blood volume. This also supports the results of previous studies investigating the 
effect of insulin in healthy volunteers and animal models (McNally et a l, 1995; 
Chen et a l, 1996).
A reduced vascular effect of insulin, seen in obese men, patients with type 2 (non­
insulin dependent) diabetes mellitus, and hamsters with streptozotocin-induced 
diabetes, has been presumed to be a feature of the pathological insulin resistant state 
in these groups (Laakso et a l, 1990; Kinoshita et a l, 2000; Bouskela et al., 1997). 
This study has demonstrated that in physiological, as opposed to, pathological 
insulin resistant conditions, the effects of insulin on the resistance vasculature are 
not diminished. This may partially explain why conditions such as type 2 diabetes 
are associated with the increased risk of micro-angiopathy (retinopathy.
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nephropathy, peripheral vascular disease), while pregnancy per se does not result in 
long-term vascular dysfunction. Insulin-mediated attenuation of the noradrenaline 
response demonstrated here, was - 1 0 % in non-pregnant women, compared to -17% 
reported by McNally in a mixed group of healthy men and women (McNally et al., 
1995). Although the vasodilatory effect of insulin in the non-pregnant patient group 
was not significant (Fig. 3.3.3), there was still a trend towards blunting of 
noradrenaline-induced tone following incubation with insulin. The lack of 
statistical significance in this instance may be due to the smaller number of patients 
recruited in this study, but does not alter the main findings.
The present study also reports no difference in noradrenaline pressor responses 
between pregnant and non-pregnant women, which agrees with the published 
literature (Knock et a l, 1996; Steele et al, 1993; Aalkjaer et a l, 1985). Although 
there was a trend towards a change in sensitivity, the difference was not statistically 
significant (Table 3.3). This finding suggests that the ‘system’ involved in the 
attenuating effect of insulin may act independently of that controlling noradrenaline 
pressor responses. It is possible that the endothelial modulation of noradrenaline 
does not play as significant a role as previously thought, as in vitro studies where 
inhibitors of nitric oxide were used showed a less significant effect in resistance 
arteries (Coats et a l, 2001; Gerber et al, 1998).
In these patients, inhibition of nitric oxide synthase resulted in significant 
potentiation of the response to noradrenaline in the pregnant but not in the non­
pregnant women. There was no alteration in the baseline response following 
incubation with L-NAME, prior to the commencement of the noradrenaline
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concentration response eurves. Within the vascular endothelium, nitric oxide 
release can be stimulated by a combination of biological mediators such as 
acetylcholine, peptides, purine metabolites and blood flow (Furchgott 1984; 
Rubanyi et a i, 1986b). In the absence of chemical stimulation from circulating 
neuro-hormonal factors, basal nitric oxide release is entirely dependent upon 
stimulation by blood flow (shear stress) on the surface of the endothelial cells. In 
vitro assessment of isolated arteries using wire myography lacks this stimulus for 
basal nitric oxide release. The significant potentiation in the noradrenaline response 
seen following nitric oxide synthase inhibition with L-NAME in pregnant women 
is, therefore, likely to be due to the inhibition of agonist-induced (noradrenaline) 
rather than basal nitric oxide. This may stimulate a concurrent increase in agonist- 
mediated nitric oxide release to modulate vascular tone, possibly via the activation 
of endothelial (31-adrenoceptors (Graves and Poston, 1993). It may be this effect 
that is observed as a potentiated vasoconstrictor response following nitric oxide 
synthase inhibition.
Insulin-mediated vasorelaxation is thought to be due to release of endothelial nitric 
oxide (Williams et a l, 1997; Scherrer et a l, 1994; Steinberg et a l, 1994), although 
other mechanisms have also been implicated(Ferrannini et a l, 1988; Creager et a l, 
1985). However, following incubation with L-NAME, vessels obtained from 
pregnant women demonstrate significant relaxation to insulin. This suggests that 
the control of peripheral vascular resistance in pregnancy does not depend entirely 
on insulin-induced nitric oxide release. Furthermore, in the presence of insulin and 
endothelial denudation, the continued and even exaggerated attenuation of 
noradrenaline-induced tone provides additional evidence that the vasodilatory effect
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of insulin is likely to be endothelium-independent. As the vasodilatory effect of 
insulin is known to act via both the endothelium and smooth muscle, one possible 
explanation for this observed effect is the activation of Ca^^-ATPase and Na' -^K' -^ 
ATPase within the smooth muscle cell and subsequent smooth muscle 
hyperpolarization (Cleland et a l, 1998; Tack et a l, 1996; Altan et a l, 1989). 
Another possibility is that as insulin is also able to stimulate the release of the 
vasoconstrictor, endothelin-1 , from the vascular endothelium, removing the source 
of endothelin- 1  production could potentially result in a larger observed vasodilatory 
effect. However, without the benefit of further research, these mechanisms are 
purely speculative.
McNally et al demonstrated that the vasodilatory effect of insulin on noradrenaline- 
induced contractility increased in a dose-dependent manner in both healthy men and 
women, and that using a l.OmU/mL concentration of insulin resulted in a maximum 
attenuation of 17% (McNally et a l, 1995). In this study, a l.OmU/mL concentration 
of insulin was chosen purely as a pharmacological tool to ensure that if present, the 
effect of insulin would be demonstrable in arteries isolated from healthy pregnant 
women, and was not intended to mimic in vivo conditions. It is possible that the use 
of this supraphysiological concentration of insulin (equating to approximately 6 nM) 
may be able to overcome a loss of insulin-induced vasodilatation associated with 
the insulin resistant state. It would, however, be of value to investigate the effect of 
lower concentrations of insulin to truly reflect normal physiological conditions.
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3,5 Conclusions
This study suggests that physiological insulin resistance and hyperinsulinaemia in 
pregnancy are not associated with the diminished vascular response to insulin 
observed in pathological states. Furthermore, insulin mediates vasorelaxation via 
an endothelium-independent mechanism. Conditions in which insulin resistance 
develops as part of the pathological process, such as type 2  diabetes, have been 
shown to be associated with a reduced vascular effect of insulin. This is not 
observed with the physiological insulin resistance associated with healthy 
pregnancies.
77
Chapter Four
Endothelium -Dependent and -Independent 
Relaxation in Pregnant Diabetic Women
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4.1 Introduction
Numerous studies have demonstrated impaired endothelial function in diabetes, 
implicating it as one of the mechanisms underlying the complications associated 
with the disorder (Johnstone et a l, 1993; McNally et a l, 1994). Abnormal vascular 
responsiveness in diabetics, due particularly to endothelial dysfunction, can 
deteriorate rapidly during pregnancy, when the ability of the maternal vasculature to 
respond rapidly to changes in metabolic requirements may be further compromised. 
The increased incidence of complications such as pre-eclampsia and placental 
insufficiency, associated with increased maternal and fetal vascular resistance, 
contributes greatly to both maternal and fetal morbidity and mortality (Garner el a l, 
1990; Redman, 1991). However, vascular dysfunction can also reflect changes in 
smooth muscle function, which may result in altered responses of the vascular 
smooth muscle to stimuli.
There is a considerable heterogeneity in the pattern of vascular dysfunction 
observed in different disease states, reflecting complex and varied underlying 
mechanisms. In general, the description of vascular dysfunction can be 
conveniently separated into two relatively simple states, endothelium-dependent or 
endothelium-independent. A state of endothelium-independent dysfunction is 
almost exclusively accepted to be due to abnormally functioning vascular smooth 
muscle. Following these straightforward criteria, an interpretation of endothelial 
dysfunction can therefore normally only be suggested if some measure of ‘normal’ 
underlying smooth muscle functionality has been made. Without this comparison, 
there would be difficulty in differentiating between endothelial and smooth muscle
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effects. A ‘misdiagnosis’ of endothelial dysfunction may therefore, in fact, be due 
to alterations in smooth muscle responses. In diabetes, where vascular dysfunction, 
particularly micro-vascular in origin, is a major contributor to morbidity and 
mortality, the specific underlying mechanisms responsible appear to differ 
according to the diabetic model and vascular bed studied. In diabetic research, a 
complex picture has emerged whereby different clinical and experimental studies 
have demonstrated both preservation and impairment of endothelium-dependent and 
-independent vasodilatation (Smits ei a i, 1993; Johnstone et a i, 1993; Heygate et 
al, 1995; Calver et al, 1992).
Nitric oxide (NO) has been one of the most widely studied endothelium-dependent 
relaxing factors, inducing vasodilatation via the guanosine 3’:5’ cyclic 
monophosphate (cGMP) pathway. It has been shown to contribute significantly to 
the control of vascular tone by studies that have shown marked vasoconstriction 
following nitric oxide synthase inhibition with analogues of L-arginine (Vanhoutte 
et a l , 1995; Bennett et a l, 1992). In most human vascular beds, the contribution of 
prostacyclin (PGIa) to endothelium-dependent relaxation is much less significant 
(Kublickiene et a l, 1997; McCarthy et a l, 1994), but along with nitric oxide, is 
thought to be associated with the physiological vasodilatation seen in pregnancy 
(Greer et a l, 1985a). Prostacyclin differs from nitric oxide in that it acts via the 
adenosine 3’:5’ cyclic monophosphate (cAMP) pathway, and can be assessed by 
inhibiting the prostacyclin-converting enzyme, cyclo-oxygenase (COX).
Until very recently, there has been little emphasis on the contribution of endothelial 
hyperpolarization to vasorelaxation. This hyperpolarization, which was initially
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thought to be due to a putative endothelium-derived hyperpolarizing factor (EDHF) 
whose precise chemical identity remains uncertain, has been shown to be insensitive 
to both nitric oxide synthase and cyclo-oxygenase inhibition (Coats et a l, 2 0 0 1 ). 
However, current literature suggests that endothelium-dependent hyperpolarization 
is more likely due to electrical coupling through myoendothelial gap junctions, 
rather than a single chemical factor (Coleman et a l, 2001a; Coleman et al, 2001b; 
Sandow and Hill, 2000). Furthermore, its importance appears to increase as the size 
of the vessel decreases, contributing significantly to the maintenance of tone within 
the resistance vasculature (Shimokawa et a l, 1996; Coats et a l, 2001). The effects 
of endothelial hyperpolarization can be inhibited by the use of 25mM potassium 
chloride, or by the combined effects of apamin and charybdotoxin (Gerber et a l, 
1998; Edwards et a l, 1998). Endothelial vasodilatory function can, therefore, be 
relatively comprehensively characterised by manipulation of nitric oxide, 
prostacyclin and endothelial hyperpolarization by inhibitors and blockers.
On the other hand, the characterisation of smooth muscle vasodilator function 
generally focuses on investigating the two most important second messenger 
systems, which transduce stimulation by either agonists or endothelial factors. As 
described above, nitric oxide and prostacyclin are the guanylate cyclase and 
adenylate cyclase systems that result in increases in cGMP and cAMP respectively. 
These pathways can be studied independently from the endothelium by exposing 
the vessels to the nitric oxide donor, sodium nitroprusside (which acts via guanylate 
cyclase), and to exogenously-applied prostacyclin (acting via adenylate cyclase).
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Cholesterol is an important lipid involved in the biosynthesis of plasma membranes, 
bile salts and steroid honnones. The tight control of plasma cholesterol is 
important, because high levels have been shown to increase the risk of ischaemic 
heart disease and stroke. Diabetes is, itself, a risk factor for atherogenesis and 
vascular dysfunction compared with the general population. Cholesterol and 
triglyceride circulate in plasma as part of various lipoprotein complexes, which 
include high-density lipoproteins (HDLs), low-density lipoproteins (LDLs), and 
very low-density lipoproteins (VLDLs). LDLs are the main transporters that carry 
cholesterol from the liver to most cells for metabolic and structural requirements, at 
the same time as enhancing arterial wall deposition and intimai thickening. HDL, 
on the other hand, promotes the removal of cellular cholesterol and its secretion into 
bile by the liver. The ratio of plasma LDL- to HDL-cholesterol, and not the actual 
plasma cholesterol level, reflects the risk of developing athersclerotic heart disease.
Plasma cholesterol levels have been shown to vary with age, pregnancy and the 
onset of the menopause, and are thought to be associated with alterations in plasma 
oestrogen levels (Stevenson et a l, 1993). During normal human pregnancy, the 
maternal plasma lipid profile undergoes a series of changes necessary for 
maintaining pregnancy, normal fetal development and preparing the mother for 
lactation. Plasma cholesterol typically increases by around 50-70% between 12 and 
36 weeks gestation. HDL-cholesterol rises to a maximum at around 28 weeks 
gestation, and then declines towards term. Triglyceride concentrations increase 
markedly by around three-fold most dramatically in the second half of pregnancy 
(Sattar «/., 1996).
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Few studies have been published investigating the influence of pre-existing type 1 
diabetes mellitus on maternal vascular responses, particularly since the important 
contribution of endothelial hyperpolarization has become clear. The aim of this 
study, therefore, was to detennine the contribution of endothelium-derived 
hyperpolarization to endothelium-dependent vascular relaxation in pregnant women 
with and without type 1 diabetes mellitus. This would be achieved by measuring 
agonist-induced vasorelaxation responses in subcutaneous resistance arteries 
following incubation with inhibitors of endothelial mechanisms. Secondly, smooth 
muscle function, distinct from endothelial effects, would be assessed by observing 
cGMP- and cAMP-dependent vasorelaxation in the same patients using specific 
endothelium-independent agonists. It is also reasonable to suggest that some 
variability in total-, HDL- and LDL-cholesterol may correlate with functional 
measures of endothelial function, more specifically, between vascular dysfunction 
and lipid derangement in pregnant women with type 1 diabetes, since there are 
abundant data from the atherogenesis field demonstrating associations between 
lipids and vaseular function (Sattar et a l, 1998; Sattar and Greer, 1999).
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4.2 Methods
4.2.1 Study groups
Local Ethical Committee approval was granted. Written informed consent was 
obtained prior to caesarean section in eleven healthy pregnant and nine diabetic 
pregnant women at term, and prior to elective laparotomy in seven healthy non­
pregnant women. All the women were normotensive and matched for maternal and 
gestational age. The diabetic women were well controlled on insulin, and did not 
require significant manipulation of their regimes with advancing gestation. The 
non-pregnant women were age-matched, fit and well, and not on any regular 
medication. Further patient characteristics including blood pressure, birthweight, 
glycosylated haemoglobin (HbAic) levels and disease duration are summarised in 
Table 4.1.
Standardising recruitment to include only women having abdominal surgery 
enabled the same vascular bed (abdominal subcutaneous resistance arteries) to be 
studied. The indications for caesarean section in the healthy pregnant women were 
previous caesarean section (seven), previous traumatic delivery (two), fetal distress 
(one) and breech presentation (one). The indications for caesarean section in the 
diabetic pregnant women were previous caesarean section (three), fetal distress 
(three) and failed induction of labour (three). The non-pregnant women were 
recruited from those admitted for elective gynaecological surgery, the indications of 
which were ovarian cystectomy (three), total abdominal hysterectomy (two), 
colposuspension (one) and myomectomy (one).
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Table 4.1 Characteristics of patients recruited into the study investigating 
endothelium-dependent and -independent vasodilatation in isolated 
small arteries.
Healthy
pregnant
Diabetic
pregnant
Healthy
non~pregnant
Significance
Age (years) 3 0 ± 2 ( n = l l ) 2 8 ± 2 (n = 8 ) 3 5 ± 3 (n = 7 ) NS
Gestational age (weeks) 39 ± 0 .2 3 7 .5+ 0 .4 - S
Birthweight (g) 3542 ±151 3991+ 242 - NS
Maternal weight (kg) 63 ± 3 72 ± 4 69 ± 6 NS
Maternal BMI (kg/m^) 25 ± 1 27 ± 1 2 6 ± 2 NS
Blood pressure (systolic) (mmHg) 114 ± 3 127 ± 4 123 ± 7 NS
Blood pressure (diastolic) (mmHg) 70 ± 3 7 9 ± 2 8 0 ± 4 NS
Smokers 1/11 0/11 3/7 -
H b A ic (% ) - 6.3 ±0.3 - -
Duration of diabetes - 15.1 ±2.1 - -
Values are expressed as mean ± standard error of the mean, n represents the 
number of women recruited. Significance assumed if p<0.05, one-way ANOVA 
and Bonferronf s post hoc test. S, significant; NS, not significant; BMI, body mass 
index; HbAjc, glycosylated haemoglobin.
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4.2.2 Experimental protocols
The standard methodology of small vessel wire myography has been explained in 
detail in Chapter 2. Only protocols and solutions specific to this chapter have been 
described.
A total of 34 small arteries with a mean luminal diameter of -295pm were dissected 
free from the biopsies obtained. The vessels isolated achieved a mean relaxation of 
84.4 ± 2.5% in healthy pregnant women, 81.5 ± 3.1% in diabetic pregnant women, 
and 82.1 ± 3.3% in non-pregnant women. Arteries that did not achieve a minimum 
relaxation of at least 60% were deemed to be unsuitable for studies of endothelial 
function and were excluded from the experiment. The rationale behind this has 
been previously explained in Chapter 2.
4.2.3 Pharmacological protocols
Four pharmacological protocols were used. All experiments were carried out in 
arteries pre-constricted with lOpM noradienaline, which produces a sustained 
maximal contraction during the duration of the response curve. However, in studies 
where vessels were incubated with 25mM potassium chloride, the concentration of 
noradrenaline was titrated to achieve a similar pre-constriction tension to previous 
cumulative concentration response curves.
1. To quantify the contribution of hyperpolarization to endothelium-dependent 
relaxation, both nitric oxide and prostacyclin were inhibited. Cumulative
86
concentration response curves were performed to carbachol (InM to 30pM), 
before and after 30 minutes incubation with:
a) N®-nitro-L-arginine methyl ester (nitric oxide synthase inhibitor, L-NAME
0.1 mM)
b) L-NAME and indomethacin (cyclo-oxygenase inhibitor, INDO 30pM)
c) L-NAME, indomethacin and 25mM potassium chloride (inhibitor of 
endothelial hyperpolarization) (Gerber et a l, 1998).
2. To study the effectiveness of cAMP and cGMP pathways in the vascular 
smooth muscle, independent of endothelial modulation. Cumulative 
concentration response curves were performed to prostacyclin (InM to 30pM) 
and sodium nitroprusside (InM to 30pM), endothelium-independent 
vasodilatory agonists dependent on cAMP and cGMP respectively.
3. To ensure that any residual relaxation following nitric oxide synthase 
inhibition was not due to an incomplete inhibition of the pathway, the vessels 
were incubated for 30 minutes with L-NAME (0,1 mM), indomethacin 
(30pM) and oxadiazoloquinoxalin, an inhibitor of soluble guanylate cyclase 
(ODQ IpM), before studies were performed with carbachol (InM to 30pM) 
and sodium nitroprusside (InM to 30pM).
4. To confirm the contribution of endothelial hyperpolarization to the residual 
relaxation response following inhibition of nitric oxide synthase and cyclo- 
oxygenase. Carbachol and sodium nitroprusside studies were repeated 
following 30 minutes incubation with charybdotoxin (lOOnM) and apamin
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(lOOnM), inhibiting both large and small conductance calcium-dependent 
potassium channels and endothelium-dependent hyperpolarization (Edwards 
et a l, 1998; Zygmunt et a l, 1997).
4.2.4 Measurement of plasma lipids
In a small number of women -eight healthy pregnant, three diabetic pregnant and 
three healthy non-pregnant, 5ml of venous blood was obtained from the ante-cubital 
fossa for measurements of plasma triglyceride, total-, HDL- and LDL-cholesterol 
levels after an overnight fast, and collected in bottles containing lithium heparin. 
The blood samples were centrifuged immediately upon collection for 10 minutes. 
The supernatant plasma was then removed and stored at -70°C, until serum analysis 
was perfoiTned.
4.2.5 Drugs and solutions
The drugs used were obtained from Sigma, Poole, UK, and CN Biosciences, 
Nottingham, UK, and made up in distilled H2O, except for indomethacin which had 
to be dissolved in dimethyl sulphoxide (DMSO). The composition of the 
physiological saline solution (PSS) used has been described in Chapter 2. 25mM 
and 123mM potassium chloride solutions (KPSS) were made by substituting NaCl 
for KCi on an equimolar basis.
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4.2.6 Statistical analysis
Relaxation is expressed as a percentage relative to the maximum tension generated 
following arterial pre-constriction with noradrenaline, mean ± standard error of the 
mean (SEM). The maximum response for each protocol was the greatest mean 
relaxation achieved and not the percentage relaxation attained at the highest 
concentration of carbachol. The number of experiments is represented as n(N), 
where n is the number of vessels and N the number of patients.
Maximum relaxation and sensitivity (pD2 -  negative log of the concentration 
required to produce 50% of the maximum response) were compared using one-way 
ANOVA and Bonferroni’s post hoc test for multiple comparisons. A p value <0.05 
was accepted as being statistically significant.
4.3 Results 
4.3.1 Myography
1. Endothelium-dependent relaxation. As there were no differences in vessel 
responses between smokers and non-smokers, all results were combined 
(Table 4.2).
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Table 4.2 Summary of maximum responses (%K^) and sensitivity (PD2 ) to 
carbachol in smoking and non-smoking patients.
Healthy pregnant 
Smokers Non-smokers
Healthy non-pregnant 
Smokers Non-smokers
n 1 10 3 4
Carbachol
Max. Relaxation (%) 94.4 92.5+ 2.3 94.6 88.3 ± 6 .8
pDz 6.7 6 .9+  0.1 6 .6 ± 0 .1 7.2 ±0.3
+L-NAME
Max. Relaxation (%) 72.3 74.4 ±4.2 81.8 ±1 .5 79.9 ± 7 .2
pDz 6.2 6.7 ±0.1 6.2 6.7 ±0.3
+L-NAME+INDO
Max. Relaxation (%) 72.1 74.5 ±4 .8 79.3 ±9.1 73.1 ±6.5
pD2 6.6 7.4 ±0.3 6.7 ±0 .5 7.0 ±0.3
+L-NAME+INDO+25mM iC
Max. Relaxation (%) 42.8 33.5 ± 8 .0 30.1 ± 0 .4 27 .5+ 9 .7
pD2 7.5 6.6 ± 0 .2 6.5 ± 0.4 5.9 ±0.3
Values are mean ± SEM. C, carbachol; L-N, L-NAME; Indo, indomethacin.
Vasorelaxation responses to carbachol were similar in all three groups of patients 
with no significant differences found in either the maximum responses or the 
sensitivity (PD2). Following incubation with L-NAME, the maximum relaxation 
was attenuated in all groups indicating a contribution of nitric oxide to endothelium- 
dependent relaxation. The maximum relaxation and pD2 data between the three 
groups are summarised in Table 4.3.
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Table 4.3 Relaxation responses of isolated arteries to carbachol with sequential 
inhibition of nitric oxide, prostacyclin and endothelial 
hyperpolarization. One-way ANOVA and Bonferroni’s post hoc test 
was carried out between the three patient groups.
Healthy
pregnant
Diabetic
pregnant
Healthy
non-pregnant
Significance
Internal arterial diameter (pm) 294 + 22 296 ± 23 293 ± 2 6 NS
Carbachol
Max. Relaxation (%) 92.6 ±2.1 95.5 ± 0 .9 89.9 ± 5 .2 NS
pÜ2 6 .8± 0 .1 7 .0± 0 .14 7.0 ± 0 .2 NS
+L-NAME
Max. Relaxation (%) 74.3 ± 3 .9 76.1 ± 3 .4 80.4 ± 5 .4 NS
pD2 6.6 ±0.1 6.7 ± 0 .2 6.5 ± 0 .2 NS
+L-NAME+INDO
Max. Relaxation (%) 74.4 ± 4 .5 74.5 ± 3 .6 74.6 ±6.3 NS
pÜ2 7.3 ± 0 .2 7.2 ±0.3 6.9 ±0.3 NS
+L-NAME+INDO+25mM K"
Max. Relaxation (%) 34.2 ± 7 .4 28.2 ± 5 .7 28.2 ±7.3 NS
pD2 6.6 ± 0.2 6.2 ± 0.2 6.0 ±0.3 NS
Values are expressed as mean ± standard error of the mean, and refer to relaxation 
to carbachol with the sequential additions of inhibitors. Significance assumed if 
p<0.05, one-way ANOVA and Bonferroni’s post hoc test. TVS, not significant; 
INDO, indomethacin.
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The contribution of nitric oxide was approximately twenty percent in the 
pregnant women regardless of whether they were diabetic, and approximately 
eleven percent in the non-pregnant women. Endothelial hyperpolarization 
appears to contribute largely to vasorelaxation in all three groups.
Figure 4.1 is an experimental concentration response curve to carbachol in an 
isolated resistance artery obtained from an insulin-dependent diabetic woman. 
Figs. 4.2.1, Fig. 4.2.2 and Fig. 4.2.3 show the cumulative concentration 
response curves as a percentage of the maximum potassium contraction to 
carbachol with the sequential inhibition of nitric oxide; nitric oxide and 
prostacyclin; and nitric oxide, prostacyclin and endothelial hyperpolarization 
in each of the three study groups.
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Fig. 4.2.1 Relaxation to carbachol ( • )  in healthy pregnant women (n = ll)  
following incubation with N^^-nitro-L-arginine methyl ester ( • ) ;  N®- 
nitro-L-arginine methyl ester and indomethacin ( • ) ;  and N“-nitro-L- 
arginine methyl ester, indomethacin and 25mM potassium chloride ( • ) .
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Fig. 4.2.2 Relaxation to carbachol (® ) in diabetic pregnant women (n=9) 
following incubation with N“-nitro-L-arginine methyl ester ( • ) ;  N"’- 
nitro-L-arginine methyl ester and indomethacin ( • ) ;  and N®-nitro-L- 
arginine methyl ester, indomethacin and 25mM potassium chloride ( • ) .
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Fig. 4.2.3 Relaxation to carbachol ( # )  in healthy non-pregnant women (n=7) 
following incubation with N®-nitro-L-arginine methyl ester ( • ) ;  N®- 
nitro-L-arginine methyl ester and indomethacin ( • ) ;  and N®-nitro-L- 
arginine methyl ester, indomethacin and 25mM potassium chloride ( • ) .
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Fig. 4.3 is a descriptive representation of the percentage contributions of each 
relaxing factor in the individual patient groups.
100 S  NO ■  PGI ■  Hypeipolaiization □  Residual-hypeipolarization
I
IDDM 
Patient groups
Fig. 4.3 Descriptive representation of the percentage contribution of nitric oxide 
(NO), prostacyclin (PGI2) and endothelial hyperpolarization to 
endothelium-dependent relaxation in healthy pregnant (P, n=ll), 
diabetic pregnant (IDDM, n=9) and healthy non-pregnant women (NP, 
n=7).
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2. When exposed to prostacyclin, no difference in maximum relaxation or 
sensitivity was observed between the groups. Fig. 4.4.1 illustrates the raw 
experimental traces to prostacyclin in all three study groups, while Fig. 4.4.2 
illustrates the maximum relaxation (%): healthy pregnant 85.8 ± 4.6%, 
n=14(ll) vs. diabetic pregnant 82.5 ± 5.0%, n=12(9) vs. healthy non-pregnant 
89.2 ± 5.4%, n=8(7). Sensitivity (pD%): healthy pregnant 6.1 ± 0.2, n=14(ll) 
vs. diabetic pregnant 6.5 ± 0.3, n=12(9) vs. healthy non-pregnant 5.9 ± 0.2, 
n=8(7).
S  50
IDDM 
Patient groups
NP
Fig. 4.4.2 Maximum relaxation to prostacyclin in isolated small arteries obtained 
from healthy pregnant (n=l 1), diabetic pregnant (n=9) and healthy non­
pregnant (n=7) women.
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Following exposure to sodium nitroprusside, no difference in maximum relaxation 
or sensitivity was observed between the groups (Fig. 4.4.3 and Fig. 4.4,4). 
Maximum relaxation (%): healthy pregnant 92.3 ± 2.2%, n=14(ll) V5. diabetic 
pregnant 95.0 ± 1.4%, n=12(9) healthy non-pregnant 99.6 ± 0.2%, n=8(7). 
Sensitivity (PD2); healthy pregnant 6.9 ± 0.2, n=14(ll) diabetic pregnant 7.3 ±
0.2, n=12(9) V6'. healthy non-pregnant 7.3 ± 0.2, n=8(7).
100 n
I
IDDM 
Patient groups
NP
Fig. 4.4.4 Maximum relaxation to sodium nitroprusside in isolated small arteries 
obtained from healthy pregnant (n=ll), diabetic pregnant (n=9) and 
healthy non-pregnant (n=7) women.
100
f
I
I I
ilO- t— <
g
S
I
d
I
%
%
I
I
§■
I
I
'Q
I
c
I
c
I
X3 --►,
I
l i
O h O
g
B
$
d
I
P h
>d
gI
d
I
P h
I
I
Î
I
I
I
I
I
Î
I
101
3. The small degree of residual relaxation following incubation with L-NAME, 
indomethacin and 25mM potassium chloride was not due to incomplete 
blockade of nitric oxide synthase since ODQ was unable to inhibit the response 
further. Maximum relaxation to carbachol in the presence of L-NAME + 
indomethacin + 25mM potassium chloride: 16.4 ± 4.9% L-NAME + 
indomethacin + 25mM potassium chloride + ODQ: 18.6 ± 4.3%, n=6(6), 
p>0.05. The observation of negligible relaxation to sodium nitroprusside 
tested the efficacy of ODQ. The maximum relaxation to SNP in the presence 
of L-NAME + indomethacin + 25mM potassium chloride 4- ODQ was 3.3 ± 
1.4%, n=6(6). The raw experimental trace and the relaxation curves expressed 
as a percentage of the maximum tension following preconstriction with lOpM 
noradrenaline are shown in Fig. 4.5.1 and Fig. 4.5.2 respectively.
4. The combination of L-NAME, indomethacin, and the toxins -apamin and 
charybdotoxin, was able to fully inhibit endothelium-dependent relaxation. 
Maximum relaxation to carbachol in the presence of L-NAME + indomethacin 
+ apamin + charybdotoxin: 1.9 ± 0.8%, n=6(6) (Fig 4.6.1 and Fig 4.6.2).
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Fig. 4.5.2 Relaxation to carbachol ( ♦ )  in healthy pregnant women (n=6) 
following incubation with N®-nitro-L-arginine methyl ester, 
indomethacin and 25mM potassium chloride (■), N®-nitro-L-arginine 
methyl ester, indomethacin, 25mM potassium chloride and 
oxadiazoloquinoxalin (A). Relaxation to sodium nitroprusside 
following incubation with N®-nitro-L-arginine methyl ester, 
indomethacin, 25mM potassium chloride and oxadiazoloquinoxalin 
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Fig. 4.6.2 Relaxation to carbachol ( ♦ )  in healthy pregnant women (n=6) 
following incubation with N“-nitro-L-arginine methyl ester,
indomethacin, apamin and charybdotoxin (■). Relaxation to sodium 
nitroprusside following incubation with K®-nitro-L-arginine methyl 
ester, indomethacin, apamin and charybdotoxin ( • ) .
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4.3.2 Plasma lipids
1. Triglycerides. Plasma triglyceride levels were around three-fold higher in 
pregnant compared to non-pregnant women, and slightly higher in the women 
with diabetes. (Healthy pregnant 3.3 ± 0.5 mmol/L, Diabetic pregnant 3.7 ± 
0.4 mmol/L, Healthy non-pregnant 1.1 ± 0.1 mmol/L, *p<0.05, Fig. 4.7).
a
}
JL
"I   ' I
IDDM 
Patient Groups
NP
Fig. 4.7 A bar graph illustrating plasma triglyceride levels in healthy pregnant 
(P), diabetic pregnant (IDDM) and healthy non-pregnant (NP) women 
(*p<0.05).
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2 . Total cholesterol. Plasma total cholesterol levels were near double in
non-diabetic and diabetic pregnant women, compared to non-pregnant 
women. (Healthy pregnant 7.2 ± 0.5 mmol/L, Diabetic pregnant 7.7 ± 0.3 
mmol/L, Healthy non-pregnant 3.6 ± 0.2 mmol/L, *p<0.01. Fig. 4.8).
IDDM 
Patient Groups
NP
Fig. 4.8 A bar graph illustrating plasma total cholesterol levels in healthy 
pregnant (P), diabetic pregnant (IDDM) and healthy non-pregnant (NP) 
women (*p<0.01).
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HDL-cholesteroL HDL-cholesterol concentrations were higher in both 
the women with healthy pregnancies, and to a lesser extent, in those with 
type 1 diabetes relative to the non-pregnant cohort, but probably due to 
smaller numbers such changes did not reach statistical significance. 
(Healthy pregnant 1.6 ± 0.1 mmol/L, Diabetic pregnant 1.4 ± 0.1 mmol/L, 
Healthy non-pregnant 1.2 ± 0.2 mmol/L, Fig. 4.9).
IDDM 
Patient Groups
X
NP
Fig. 4.9 A bar graph illustrating HDL-cholesterol levels in healthy pregnant (P), 
diabetic pregnant (IDDM) and healthy non-pregnant (NP) women.
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4. LDL-cholesterol. LDL-cholesterol was approximately two to two-and-a- 
half times higher in the pregnant compared to the non-pregnant women. 
(Healthy pregnant 4.2 ± 0.4 mmol/L, Diabetic pregnant 4.6 ± 0.4 mmol/L, 
Healthy non-pregnant 1.9 ± 0.3 mmol/L, Fig. 4.10).
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Fig. 4.10 A bar graph illustrating LDL-cholesterol levels in healthy pregnant (P), 
diabetic pregnant (IDDM) and healthy non-pregnant (NP) women.
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4.4 Discussion
This study provides evidence that pregnant women with well-controlled pre­
existing type 1 diabetes mellitus have normal endothelial and smooth muscle 
function in subcutaneous resistance vessels taken from the anterior abdominal wall. 
Furthermore, endothelial hyperpolarization appears to contribute largely to 
endothelium-dependent relaxation in pregnant women both with and without 
diabetes.
There is no apparent impairment of endothelial function in pregnant women with 
type 1 diabetes, which supports previous studies suggesting that endothelial 
function is maintained in patients with uncomplicated type 1 diabetes (McIntyre et 
ai, 2001; Smits et al, 1993). These observations, in isolated subcutaneous 
resistance arteries obtained from the anterior abdominal wall, may be due to one of 
two reasons. Firstly, the assessment of endothelial function is determined by the 
degree of agonist-mediated vasorelaxation following pre-constriction. However, 
once a vessel reaches complete relaxation, any further increases in arterial luminal 
diameter cannot be achieved. Therefore, if present, a small degree of endothelial 
dysfunction may be unobservable in the diabetic women due to the increased 
vasodilatation associated with pregnancy. Secondly, the patients recruited were 
young women with a relatively shorter disease duration and tighter glycaemic 
control (due to closer supervision at joint medical/ante-natal clinics). This is 
reflected by the mean HbAic level, birthweight at delivery, and the delivery of the 
infants at term (>37 weeks) in this study population.
I l l
This study has also shown a preservation of smooth muscle function in pregnant 
women with type 1 diabetes, as responses to both prostacyclin and sodium 
nitroprusside were similar in all three groups of women. This implies that the 
nomal activation of the second messenger pathways, cAMP and cGMP, in vascular 
smooth muscle following agonist stimulation is maintained in pregnant women with 
type 1 diabetes mellitus. Vascular smooth muscle tension is regulated by various 
vasoactive substances, which, in turn, modulate blood flow. In vivo, the resting 
tensions of smooth muscle (or the background tone) depend on a balance between 
endogenously produced vasodilators, such as nitric oxide, and vasoconstrictors 
including endothelin-1 and thromboxane A2 . The sequence of events that evokes 
smooth muscle responses is achieved by agonist-induced changes in the 
intracellular concentrations of second messenger molecules (Shaw and McGrath, 
1996). The initiation of these responses is achieved by the interaction of the second 
messenger molecules with specific receptors located either in the plasma membrane 
or intracellular structures. The present experiments deal with the assessment of the 
cAMP and cGMP second messenger pathways via adenylate cyclase and guanylate 
cyclase, independent of the endothelium. Stimulation of these enzymes results in 
elevated intracellular concentrations of cAMP and cGMP, reduced intracellular 
calcium concentrations and smooth muscle relaxation. The normal vasodilatory 
response of the vessels studied suggests that the ability/sensitivity of the smooth 
muscle to respond to nitric oxide and prostacyclin is not impaired in pregnant 
diabetic women. As stated in the introduction, this observation is important for the 
correct understanding of the endothelium-dependent results, particularly those 
involving endothelium-derived nitric oxide and prostacyclin.
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The literature has suggested an increased role of endothelium-dependent relaxing 
factors during pregnancy, contributing to significant vasodilatation (Greer et ai, 
1985a; Williams et al, 1997). However, previous studies have mainly concentrated 
on contributions by nitric oxide and prostacyclin with little emphasis on the 
importance of endothelium-derived hyperpolarization. These data appear to 
demonstrate an increased contribution of nitric oxide of approximately twenty 
percent in pregnant women and approximately eleven percent in non-pregnant 
women. However, the contribution of endothelial hyperpolarization is, 
qualitatively, at least twice that of nitric oxide in pregnant women, and five-fold 
greater in non-pregnant women, supporting other studies which suggest that 
endothelium-dependent hyperpolarization may be more prominent in resistance 
arteries (Coats et al, 2001; Gerber et al, 1998; Shimokawa et al, 1996). It is 
possible, however, that the blockade of one vasodilatory pathway may result in a 
proportionately greater contribution from another pathway. However, limited by 
the constraints if time, it was not possible to assess the relative importance of 
endothelial hyperpolarization on its own, without inhibiting nitric oxide and 
prostacyclin. As yet, a precise chemical factor responsible for endothelium-derived 
hyperpolarization remains to be identified, but a P450 cytochrome-derivative is 
thought to be involved in human subcutaneous small arteries (Coats et al, 2001). 
However, more recent evidence suggests that electrical propagation across 
myoendothelial gap junctions is likely to account for the endothelial 
hyperpolarization, and therefore the failure to identify a single chemical factor as 
EDHF (Coleman et al, 2001a; Coleman et al, 2001b; Coats et a l,  2001; Edwards 
et al, 1998),
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Following combined inhibition with L-NAME, indomethacin and 25mM potassium 
chloride, a residual relaxation o f-30% was still observed in the carbachol response, 
which was either due to incomplete inhibition of nitric oxide or endothelial 
hyperpolarization. Two assumptions were important if this dataset was to be 
interpreted as taie residual relaxation. Firstly, it was assumed that L-NAME had 
successfully blocked all production of nitric oxide. Secondly, it was assumed that 
25mM potassium chloride could fully eliminate endothelium-dependent 
hyperpolarization. Earlier studies suggested that L-NAME may not fully inhibit the 
nitric oxide synthase pathway (Chauhan et al, 2000), and Gerber et al reported that 
pre-incubation with 25mM potassium chloride completely abolished the effects of 
endothelium-derived hyperpolarization in rat mesenteric arteries (Gerber et al,  
1998). In this study, the efficacy of L-NAME was confirmed by incubating the 
vessels with L-NAME, indomethacin, 25mM potassium chloride, and 
oxadiazoloquinoxalin (ODQ, an inhibitor of cGMP production). In the presence of 
ODQ, no further inhibition of the carbachol response was observed. The efficacy of 
ODQ (IjuM) was tested by repeating that protocol with the nitric oxide donor, 
sodium nitroprusside. As sodium nitroprusside only showed -3% relaxation in the 
presence of ODQ, it appeared extremely unlikely that the remaining relaxation in 
the carbachol experiments was due to incomplete nitric oxide synthase inhibition. 
Similarly, to confinn the efficacy of 25mM potassium chloride as a blocker of 
hyperpolarization, the experiments were repeated with the potassium solution 
substituted with apamin (lOOnM) and charybdotoxin (lOOnM) (known to inhibit 
both small and large conductance calcium-dependent potassium channels and thus 
endothelium-dependent hyperpolarization (Edwards et al, 1998). The combination 
of charybdotoxin and apamin abolished the residual relaxation (in the carbachol
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experiments), suggesting that the previous residual relaxation had been due to the 
incomplete inhibition of endothelial hyperpolarization (Fig. 4.1).
The non-nitric oxide, non-prostanoid effect appears to be sensitive to the combined 
effects of apamin and charybdotoxin, suggesting an involvement of large and small 
conductance calcium-dependent potassium channels. However, potassium itself can 
induce a direct hyperpolarization and relax smooth muscle by either stimulating 
ouabain-sensitive sodium-potassium-ATPase, inward-rectifying potassium 
channels, or stimulate the release of a ‘vasodilator mediator(s)’ from perivascular 
nerves that induce endothelium-dependent vasodilatation (McCarron and Halpern, 
1990; Knot et al,  1996; Rubanyi and Vanhoutte, 1988). Pascoal and Umans 
explored endothelium-dependent vasodilatation in human omental resistance 
arteries, focusing on the action of nitric oxide-independent relaxing factors in both 
pregnant and non-pregnant women (Pascoal and Umans, 1996). They showed that 
vessels obtained from pregnant women relaxed to bradykinin in the presence of 
nitric oxide synthase, cyclo-oxygenase and non-selective potassium channel 
blockade, while vessels obtained from non-pregnant women showed minimal (12%) 
relaxation in the presence of the same three inhibitors. In contrast to my findings, 
they also suggested that endothelium-dependent vasodilatation pregnancy may be 
associated a hyperpolarizing vasodilator, which may not be a potassium channel 
factor.
The failure of 25mM potassium chloride to abolish endothelial hyperpolarization in 
human subcutaneous arteries when it has been shown to be effective in rat 
mesenteric arteries, may be due to the fact that the hyperpolarizing effect now
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seems more likely to be due to electrical coupling, rather than a single identifiable 
chemical factor (Coleman et ai, 2001a; Coleman et al,  2001b; Sandow and Hill, 
2000). In the present study, the contribution of hyperpolarization to endothelium- 
dependent relaxation may therefore be more important than previously thought. In 
this study, it is responsible for approximately eighty percent of the total 
vasorelaxation response to carbachol, with no observable difference between the 
patient groups. However, this assumes that the mechanisms underlying vascular 
function act independently of each other. It is possible that inhibiting nitric oxide 
production may in fact enhance the potency of endothelial hyperpolarization. The 
role of endothelial hyperpolarization may therefore only appear to be increased in 
comparison to that if nitric oxide. Moreover, the earlier suggestion that prostacyclin 
may be an important mediator of vascular tone in pregnancy, is not supported by 
this data. Although prostacyclin does contribute slightly more to relaxation in non­
pregnant compared to pregnant women, when compared to endothelial 
hyperpolarization the effect is considerably less important.
Diabetic patients who demonstrate impaired vasodilatation may reflect either 
underlying structural or functional abnormalities within the endothelium and/or 
smooth muscle. It is possible that the elevated levels of free radicals produced in 
poorly controlled diabetes may contribute to this dysfunction. The different 
manifestations of diabetes on vascular smooth muscle function appear to differ 
between different populations. The large majority of studies demonstrate impaired 
vasodilatation to endothelium-dependent agonists in the presence of preserved 
responses to endothelium-independent vasodilators in type 1 diabetes (Johnstone et 
al, 1993; McNally et al, 1994). However, others have also demonstrated impaired
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endothelium-independent vasodilatation in diabetes (Calver et al, 1992). This 
suggests that diabetes does not appear to cause a generalised reduction in the 
sensitivity of smooth muscle to endogenous vasodilators.
As expected from previous literature, levels of triglycerides (and VLDL- 
cholesterol), total- and LDL-cholesterol were increased in pregnant compared to 
non-pregnant women, as were HDL-cholesterol concentrations to a lesser extent. 
The co-existence of diabetes during pregnancy may affect lipid metabolism, 
however due to the small numbers of available plasma for lipid analysis in this 
study, we were unable to address this potential. It is of note, however, that others 
have revealed deleterious alterations in lipids with poorly controlled diabetes in 
pregnancy, with higher triglyceride and lower HDL-cholesterol levels relative to 
healthy pregnant women (Merzouk et al, 2000).
Studies have demonstrated that abnormal lipid patterns (especially oxidised LDL 
which is raised in diabetes) can inactivate nitric oxide and result in vascular damage 
(Schmidt et al, 1991; Bucala et al, 1991; Sattar et al, 1998). Furthermore, the 
lipid changes observed during poorly controlled diabetic pregnancies have been 
shown to be greater than in non-diabetic pregnancies, but in women with good 
control, lipid changes are comparable to normal pregnancy (Merzouk et al, 2000). 
Plasma cholesterol and triglyceride concentrations are known to rise in pregnancy, 
with the increase in triglyceride concentrations being primarily due to an increase in 
VLDL-cholesterol concentrations (Potter and Nestel, 1979; Sattar et al, 1997). 
Although analysis of plasma lipids was carried out on a small number of women, 
the apparent trend demonstrates a significant elevation of triglyceride, total- and
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LDL-cholesterol in pregnant women as would be expected. These increases may be 
important in meeting the metabolic demands of the fetus, and to prepare the 
expectant mother for lactation. There did not appear to be any difference in either 
lipid levels or vascular function between diabetic and non-diabetic pregnant 
women, which may reflect the relatively tighter degree of glycaemic control and the 
apparent presence of uncomplicated disease in these women.
No significant difference was observed in the HDL-cholesterol levels between the 
diabetic/non-diabetic pregnant and the non-pregnant women, which may be due to 
the small number of women studied. The literature suggests that mean HDL- 
cholesterol levels peak at 28 weeks gestation, and are significantly higher in 
pregnant compared to the non-pregnant women (Sattar et al, 1996). Other studies 
have also suggested that the increase in HDL-cholesterol may be due to the elevated 
oestrogen levels in pregnancy, promoting the hepatic synthesis of HDL and 
reducing hepatic lipase activity (Sattar and Greer, 1999; Desoye et al, 1987).
4.5 Conclusions
This study provides evidence that pregnant women with well-controlled pre­
existing type 1 diabetes have both normal endothelial and smooth muscle function 
in isolated subcutaneous abdominal resistance arteries. Endothelial 
hyperpolarization appears to contribute largely to endothelium-dependent relaxation 
in human subcutaneous arteries, and is not altered by pregnancy or the presence of 
diabetes in pregnancy. Furthermore, there did not appear to be any suggestion of 
abnormal lipid patterns in the diabetic women, which may reflect the importance of
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good metabolic control. The physiological increase in peripheral vasodilatation in 
pregnancy may contribute to the maintenance of vascular function and tissue 
perfusion in pregnant diabetic women. Although underlying diabetes does have 
some effect on the pregnant mother, fears of endothelial dysfunction leading to 
damaging vascular disorders are probably unfounded in well-controlled diabetics.
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Chapter Five
The Effect of Endothelin-l on Vasoconstrictor 
Responses in Pregnant Women with 
Type 1 Diabetes Mellitus
120
5.1 Introduction
The preceding chapters of this thesis have examined the vasodilatory effect of 
insulin on subcutaneous resistance arteries in healthy pregnant women, and 
endothelium-dependent relaxation in pregnant women with and without type 1 
diabetes mellitus. As well as vasodilator mechanisms, the assessment of vascular 
function should also involve the study of vessel responses to endogenous 
vasoconstrictors, such as nordarenaline and endothelin-1.
Endothelin-1 (ET-1) is an endothelium-derived vasoconstrictor peptide that 
contributes to basal vascular tone, and is also thought to play a role in pregnancy, 
both from a maternal (utero-placental function) and fetal (embryogenesis) 
perspective (Bobik et al, 1990; Douglas and Ohlstein, 1997). Its potent 
vasoconstrictor properties have implicated it in the pathogenesis of diseases 
associated with abnormal vascular function, such as pre-eclampsia and hypertension 
(Wolff et al, 1996a; Lind et a l, 1999)
It has been suggested that the pathogenesis of diabetic micro-angiopathy involves 
an initial increase in micro-vascular blood flow leading to micro-vascular sclerosis 
and disturbed autoregulation (McAuley et al, 2000). Alterations in the 
vasoconstrictor response to ET-1 in diabetes may therefore result in hyperperfusion 
and subsequent micro-vascular damage. Elevated insulin levels have been linked to 
increased endothelin receptor expression, possibly by up-regulating endothelin 
receptors (Wu et a l, 2000), while vasoconstrictor responses to ET-1 have been 
shown to be enhanced in insulin resistant arteries due to an enhanced expression of
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ET receptors and underlying endothelial dysfunction (Katakam et a i, 2001). 
Hyperinsulinaemia and insulin resistance may result in an imbalance between the 
action of nitric oxide and endothelin-1, thereby increasing vascular tone and 
vascular dysfunction. It is possible that the elevated plasma ET-1 levels seen in 
diabetic patients may be one of the factors contributing to the development of the 
vascular complications of the disease. Plasma levels have been shown to remain 
constant throughout pregnancy, with similar levels seen in non-pregnant women, 
but doubled in pregnant women with diabetes (Wolff et a l, 1997). This may be an 
important finding due to the fact that pregnant women with diabetes are at an 
increased risk of developing pre-eclampsia compared to their non-diabetic 
counterparts.
As physiologically elevated levels of insulin are seen in healthy pregnant women, 
the interaction between insulin and ET-1 may be amplified in pregnancy, especially 
in the presence of (pre-pregnancy) diabetes. Although I have demonstrated a 
preservation of endothelial and smooth muscle function in this particular group of 
type 1 diabetic pregnant women, changes in the response of subcutaneous resistance 
arteries to ET-1 may still be demonstrated in these women. This study aims to 
investigate the effect of type 1 diabetes on the vasoconstrictor response to ET-1 in 
pregnant women. It is hypothesised that isolated arteries obtained from pregnant 
women with diabetes will demonstrate differences in both maximum response and 
sensitivity when exposed to ET-1 compared to non-diabetic pregnant women.
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5.2 Methods
5.2.1 Study groups
Local Ethical Committee approval was granted, and the study carried out in 
accordance with the Declaration of Helsinki (1996). Written informed consent was 
obtained prior to caesarean section in nine non-diabetic pregnant women and seven 
diabetic pregnant women; and prior to laparotomy in five non-diabetic non-pregnant 
women. All women were nonnotensive and matched for maternal and gestational 
age. Diabetic patients were well controlled on insulin, and did not require 
significant manipulation of their regimes with advancing gestation. Further patient 
characteristics including blood pressure, birthweight, HbAic levels and disease 
duration are summarised in Table 5.1.
Standardising recruitment to include only women having abdominal surgery 
enabled the same vascular bed to be studied. The indications for caesarean section 
in the healthy pregnant women were fetal cardiac anomaly (one), breech 
presentation (one), multiple pregnancy (one) and previous caesarean section (six). 
The indications for caesarean section in the diabetic pregnant women were previous 
caesarean section (two), fetal distress (four) and failed induction (one). All non­
pregnant women underwent elective gynaecological surgery.
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Table 5.1 Characteristics of patients recruited into the study investigating effect of 
endothelin-1 on isolated small arteries.
Healthy
pregnant
Diabetic
pregnant
Healthy
non-pregnant
Significance
Age (years) 31 ± 1 (n=9) 2 9 ± 2 (n = 7 ) 3 7 ± 3 (n = 5 ) S
Gestational age (weeks) 39.4 ±0.3 37 .3+ 0 .4 - S
Birthweight (g) 3677 ± 163 4040 ±271 - NS
Blood pressure (systolic) (mmHg) 120 ± 4 127 ± 5 126 ± 5 NS
Blood pressure (diastolic) (mmHg) 74 ± 3 78 ± 2 7 9 ± 4 NS
Smokers 2/9 0/7 1/5 -
HbAic (%) - 6.2 ± 0 .4 - -
Duration of diabetes (years) - 16.6 ± 1.9 - -
Values are expressed as mean ± standard error of the mean, n represents the 
nmnber of women recruited. Significance assumed if p<0.05, one-way ANOVA 
and Bonferroni’s post hoc test. S, significant; NS, not significant; HbAjc, 
glycosylated haemoglobin.
5.2.2 Experimental protocols
The standard methodology of small vessel wire myography has been explained in 
detail in Chapter 2. Only protocols and solutions specific to this chapter have been 
described.
Small arteries ~280|Ltm were dissected free from the biopsies of subcutaneous fat 
obtained at laparotomy. The vessels isolated achieved a mean relaxation of 70.1 ±
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2.8% in healthy pregnant women, 71.9 ± 7.2% in diabetic pregnant women, and 
71.7 ± 3.2% in non-pregnant women.
5.2.3 Pharmacological protocols
Two pharmacological protocols were used:
Study 1 -  Cumulative contraction curves (CRCs) were performed to noradrenaline 
(InM to 30 pM).
Study 2 -  CRCs to ET-1 (IpM to 0.3pM) were carried out.
5.2.4 Drugs and solutions
All drugs were obtained from Sigma, Poole, UK, and made up in distilled H%0. PSS 
and KPSS were made up as described in Chapter 2.
5.2.5 Statistical analysis
Contractile responses to potassium were expressed as isometric tension in mN/mm. 
Responses to noradrenaline and ET-1 were expressed as a percentage of each 
individual vessel’s maximum potassium contraction, allowing for the 
standardization of responses between vessels. Data are expressed as the mean ± 
standard error of the mean (SEM). The number of experiments is represented as 
n(N), where n is the nmnber of vessels and N the nmnber of patients.
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In this study, maximum contraction and sensitivity (pD2 -  negative log of the 
concentration required to produce 50% of the maximum response) were compared 
using Student’s t test, with a p value <0.05 being accepted as statistically 
significant.
5.3 Results
As there were no differences in vessel responses between the smokers and non- 
smokers, all results were combined (Table 5.2).
Table 5.2 Summary of maximum responses (%K^) and sensitivity (PD2) to 
endothelin-1 in smoking and non-smoking women.
Healthy pregnant 
Smokers Non-smokers
Healthy non-pregnant 
Smokers Non-smokers
n 2 7 1 4
Max. Response (%) 134.6 ±11.9 147.6 ±15.1 111.0 99.9 ± 10.3
pDz 5.4 ±0.3 5.5 ±0.1 4.9 5.4 ±0.3
Values are mean ± SEM.
There was also no significant difference in the maximum response to or 
noradrenaline between the three groups of women. These results are summarised in 
Fig. 5.1 and Fig. 5.2.
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Fig. 5.1 A bar graph of the maximum vessel responses to potassium (K )^ in 
healthy pregnant (P), diabetic pregnant (IDDM) and healthy non­
pregnant (NP) women.
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Fig. 5.2 A bar graph of the maximum vessel responses to noradrenaline in 
healthy pregnant (P), diabetic pregnant (IDDM) and healthy non­
pregnant (NP) women.
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The raw experimental traces of resistance arteries exposed to cumulative 
concentrations of endothelin-1 in each of the three study groups -healthy pregnant, 
diabetic pregnant and healthy non-pregnant women are shown in Fig 5.3.
The maximum response to ET-1 was significantly increased in pregnant compared 
to non-pregnant women [Maximum response (%K'*') non-diabetic pregnant: 142.4 ± 
12.4%, n=9(9) vs. non-pregnant: 101.8 ± 8.8%, n=6(5) *p<0.05. Fig. 5.4]. No 
difference in the maximum response was seen between the diabetic and non­
diabetic pregnant women [Maximum response (%K’^  non-diabetic pregnant: 142.4 
± 12.4%, n=9(9) v& diabetic pregnant: 138.3 ± 6.8%, n=8(7)].
Endothelin (pregnant) 
Endothelin (non-pregnant)
160 -I
120 -
80 -
40 -
-12 -11 -10 9 -8 ■7
ET-1 (Log M)
Fig. 5.4 The effect of endothelin-1 (ET-1) on isolated small arteries obtained 
from healthy pregnant and non-pregnant women C^p<0.05).
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Sensitivity to ET-1 was significantly reduced in the pregnant diabetic women 
compared to the non-diabetic pregnant women [pD2 non-diabetic pregnant: 5.5 ± 
0.1, n=9(9) vs. diabetic pregnant: 4.8 ± 0.2, n=8(7) *p<0.05. Fig. 5.5]. No 
difference in sensitivity was seen between the healthy pregnant and non-pregnant 
women [pDz non-diabetic pregnant; 5.5 ± 0.1, n=9(9) v& non-pregnant: 5.3 ± 0.2, 
n=6(5)].
■ Endothelin (pregnant) 
■Endothelin (diabetic pregnant)
160 n
120 -
I
V
12 -11 -10 9 8 -7
ET-1 (Log M)
Fig. 5.5 The effect of endothelin-1 (ET-1) on isolated small arteries obtained 
from healthy pregnant and diabetic pregnant women (pD%, *p<0.05).
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5.4 Discussion
The main findings in this study were a significant increase in the maximum 
vasoconstriction response to ET-1 in pregnant compared to non-pregnant women, 
and a significant reduction in sensitivity to ET-1 in pregnant women with type 1 
diabetes compared to healthy pregnant women.
Endogenous ET-1 appears to contribute to the regulation of basal vascular tone and 
systemic blood pressure by a balanced activation of ETa and ETb receptors, 
stimulating both vasoconstriction directly and vasodilatation via nitric oxide release 
(Haynes and Webb, 1998). Studies have demonstrated ET-1 as a significant 
regulator of placental blood flow, and an important factor in fetal development 
(Sabry et a l, 1995; Kohnen et a i, 1997; Kurihara et a l, 1994; Clouthier et a l, 
1998). Furthermore, it is also thought to have a role in placental growth due to its 
mitogenic properties, and in the closure of umbilical vessels at birth (Fant et a l , 
1992; Nisell et a l, 1990). Plasma ET-1 levels have been shown to be significantly 
elevated in conditions associated with vascular dysfunction such as diabetes 
mellitus, pregnancy-induced hypertension and chronic cardiac failure (Wolff et al, 
1997; Kamoi et a l, 1990; Kiowski et a l, 1995). In one of the largest reported 
longitudinal studies, plasma levels of ET-1 in pregnancy were observed to be in the 
picomolar range, although no measurements have been possible of local or tissue 
levels, which may have more significance (Wolff et a l, 1997). As the vascular 
effects of ET-1 are either autocrine or paracrine, tissue levels are of greater 
importance compared to plasma levels in terms of their influence on the resistance 
vasculature. In this study, supraphysiological concentrations of ET-1 were used to
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demonstrate the pharmacological effects of the peptide in the different patient 
groups, which give an indication of the maximum response that can be achieved by 
the tissue and may not reflect the effect found at physiological concentrations.
As there were no differences in responses either to potassium or noradrenaline, the 
results of this study are specific to ET-1. This suggests that any alteration in ET-1 
response is more likely to be secondary to changes in receptor expression and not 
the second messenger pathway within the smooth muscle (McIntyre et a l, 2001). 
This study shows a significant increase in the maximum vasoconstrictor response to 
ET-1 in pregnancy, reflecting the ability of the vessels to respond to the peptide. 
This finding suggests that the normal vascular changes in pregnancy may be partly 
modified by the presence of ET-1. The non-pregnant women recruited into the 
study were slightly older than the pregnant women. However, this is unlikely to 
significantly alter vascular function, as the age difference was less than ten years, 
and all the non-pregnant women were pre-menopausal, with no increased incidence 
in smoking.
In contrast, the findings in pregnant diabetic women show a different type of effect, 
with an attenuation of vascular tissue sensitivity to ET-1, but no change in 
maximum vasoconstrictor response. This implies that vessels obtained from 
pregnant diabetic women require a higher concentration of ET-1 to produce a 
similar response, which may reflect vascular dysfunction. However, the diabetic 
women in our study achieved good glycaemic control, as reflected by the mean 
HbAic level, birthweight at delivery, and the delivery of the infants at term (>37 
completed weeks of gestation). It is possible that the reduction in sensitivity
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observed in pregnant diabetic women may be secondary to a down-regulation of 
ETa receptor signalling in response to a rise in plasma ET-1 levels. Wolff et al. 
demonstrated that resistance vessels pre-treated with the ETa receptor antagonist, 
BQ-123, showed a similar shift in the response curve to the right and a reduction in 
sensitivity to ET-1 (Wolff et a l, 1996b). Previous studies have also demonstrated 
changes in vascular tissue sensitivity to other endogenous vasoconstrictor peptides 
during pregnancy. Gant et al showed that healthy pregnant women were 
remarkably resistant to the pressor effects of infused angiotensin II (Gant et a l, 
1973), and that the likely explanation for this reduction in sensitivity was the 
increased plasma angiotensin II concentrations seen during pregnancy (Robertson et 
al, 1971).
The absence of a group of young non-pregnant type 1 diabetic women does not 
allow the effect of pregnancy on ET-1 responses in type 1 diabetic women to be 
studied. However, there would be significant difficulty in recruiting a sufficient 
number of young diabetic women undergoing laparotomy, and it would have been 
necessary to obtain the vessels from gluteal biopsies.
In a recent study by McIntyre et a l, vascular responses to ET-1 were studied in a 
mixed sample of both male and female type 1 diabetic and non-diabetic subjects 
(McIntyre et a l, 2001), They reported an increase in ET-1 sensitivity with no 
change in maximum response in the diabetic group, and suggested that these 
findings may be due to either a down-regulation of ETbi receptors, or an up- 
regulation of ETa/ETb2 receptors. Another possibility would be the increased 
production of ET-1 resulting from a reduction in tissue sensitivity due to vascular
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damage. However, this type of response is much less well understood. The greater 
importance of the vasoconstrictor pathway suggests that the elevated plasma ET-1 
concentrations seen in diabetics is more likely to result in a down-regulation of 
ETa/ETb2 receptors, and be observed as a reduction in tissue sensitivity to ET-1. 
Unfortunately, ET-1 levels were not measured in this study.
Insulin has been shown to increase ET-1 production, receptor synthesis and gene 
expression (Frank et a l, 1993; Hu et al, 1993). Wolff et al reported constant 
plasma ET-1 levels throughout pregnancy similar to non-pregnant women, but 
significantly elevated in diabetic pregnant women (Wolff et a l, 1997). If insulin 
increases ET-1 production, one would expect elevated plasma ET-1 levels in 
healthy pregnant women who are physiologically insulin resistant and 
‘hyperinsulinaemicf Therefore, the raised ET-1 levels seen in diabetics are 
unlikely to be due to exogenous insulin administration, but rather to diabetes per se. 
The role of glucose in the vascular effects of ET-1 is unclear. Studies have reported 
both increased and decreased ET-1 release in endothelial cell cultures following 
glucose administration (Yamauchi et a l, 1990; Hattori et a l, 1991; Ferri and De- 
Mattia, 1995).
5.5 Conclusions
This study has shown that pregnancy is associated with a greater maximum 
response to ET-1, while diabetes reduces ET-1 sensitivity in the peripheral 
vasculature. These important observations suggest that the presence of disease may
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significantly alter vessel sensitivity to circulating peptides, and result in an 
increased disposition to developing micro-vascular disease.
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Chapter Six
Final Conclusions
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6.1 Summary
Extensive research has been carried out investigating vascular function in both type 
1 and type 2 diabetics. The complexity of the aetiology and progression of diabetes 
has led to a wide range of observations that appear to depend on patient age, disease 
duration, level of glycaemic control, the co-existence of micro-vascular 
complications, the species, and even the vascular bed studied. Studies in type 1 
diabetics have demonstrated both impaired and normal endothelial function, 
whereas in type 2 diabetics and in type 2 post-menopausal diabetics only abnormal 
function has been reported. The complications associated with diabetes,
particularly those of micro-vascular origin, are amplified in pregnancy, and can lead 
to devastating pregnancy outcomes for both the mother and the fetus. This 
contributes significantly to patient morbidity and the demands on health care. 
Many of the problems associated with diabetic pregnancies are thought to stem 
from damage to the small vessels that control peripheral resistance, and ultimately 
tissue perfusion. There has been very little published literature on vascular function 
in younger women with type 1 diabetes, especially during pregnancy. This thesis 
has examined some of the factors involved in the control of vascular function in 
subcutaneous resistance arteries from pre-pregnancy type 1 diabetic pregnant 
women.
Pregnancy is an insulin resistant state, where resulting hyperinsulinaemia becomes 
necessary to maintain maternal nonnoglycaemia and normal fetal development. A 
significant physiological maternal vasodilatation develops, evident as early as five 
weeks gestation, that becomes more pronounced in the second trimester. This
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occurs as a consequence of vast increases in blood volume and cardiac output 
needed to maintain the fetal-placental circulation, and may be due, in part, to an 
increase in nitric oxide and prostacyclin production.
The first part of this thesis examines the vasodilatory effect of insulin on resistance 
arteries obtained from physiologically insulin resistant pregnant women. The study 
demonstrates that insulin is able to significantly attenuate noradrenaline-induced 
vasoconstriction in healthy pregnant women independent of the endothelium. This 
suggests that insulin may partially contribute to the physiological vasodilatation 
observed in pregnancy through changes in vascular smooth muscle tone.
Women with type 1 diabetes require higher levels of exogenous insulin during 
pregnancy to maintain maternal and fetal health, and to compensate for the 
physiological insulin resistance that develops. These women are at a higher risk of 
developing pregnancy-induced hypertension, and may experience rapid 
deterioration of pre-existing micro-vascular complications, compared to non­
diabetic women. Chapter 4 investigates both endothelial and smooth muscle 
function in subcutaneous resistance arteries in pregnant women with and without 
diabetes, and demonstrates not only normal vascular function in the diabetic 
women, but that endothelial hyperpolarization appears to contribute greatly to the 
control of vascular tone in these arteries. The mechanisms underlying the 
regulation of vascular function in diabetics are multi-factorial, and may depend on 
disease progression, evolution and control. An abnormal lipid profile, seen more 
commonly in diabetics, can also contribute to endothelial damage. Various lipid 
markers, such as triglycerides, total-, HDL- and LDL-cholesterol, have been
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investigated in the different groups of women, and suggest that this particular group 
of diabetic women do not have abnormal lipid profiles when compared to non­
diabetic pregnant women. This supports the in vitro myography assessments of 
vascular function.
Diseases affecting tissue responses to vasoactive substances can be observed, in 
vitro, as changes in vascular sensitivity to chosen agonists. The effect of 
endothelin-1 (ET-1) on vasoconstrictor responses in diabetic pregnant women was 
examined. ET-1, one of the most potent endogenous vasoconstrictors known, is 
synthesised primarily by the vascular endothelium and has been implicated in 
hypertension and cardiac disease, and in the increased incidence of pre-eclampsia 
seen in diabetic women. Besides its vasodilatory effects, insulin is also known to 
stimulate ET-1 release, which may be critical in diabetic pregnancies. This study 
shows that pregnancy is associated with a marked increase in the maximum ET-1 
response, while the presence of diabetes in pregnancy results in a significant 
reduction in tissue sensitivity to ET-1. These observations suggest that ET-1 may 
be important in regulating peripheral resistance in pregnancy, and may contribute to 
the increased disposition of diabetics to developing arterial disease.
There were several technical drawbacks with the study. Firstly, using a 
95%02/5%C02 mixture results in a partial pressure of O2 well outside the 
physiological range (>600mmHg). This hyperoxic enviromnent can be problematic 
due to potential superoxide ion generation, which can be a source of variability, 
particularly in the study of nitric-oxide-mediated responses. However, the reason 
behind the use of this ‘gassing’ mixture is to maintain the pH of the particular
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physiological salt solution used in the organ bath during the in vitro study of 
isolated resistance arteries at 37°C. Historically, this experimental condition has 
been commonly used for studies on vascular (and endothelial) function, therefore, 
despite its limitations comparison with other studies is easier to address. Secondly, 
another limitation of using wire myography as a means of investigating the 
functional characteristics of resistance arteries is the inability to satisfactorily mimic 
normal physiological changes, such as alterations in intraluminal pressure and shear 
stress. An alterative method of assessing small vessel function that would take this 
factor into account is pressure myography (Coats et a l, 2001;Doughty et a l, 2000). 
Thirdly, the total number of patients recruited was much higher than the number 
from which biopsies were actually obtained. A coded sticker on their case files 
identified all recruited patients, alerting admitting medical/midwifeiy staff of their 
participation in the study. However, several of the recruited women who had 
emergency caesarean sections were missed because of the urgency of delivery. 
Furthennore, a few women delivered out of hours at a time when laboratory access 
could not be arranged. Other problems included difficulty in isolating subcutaneous 
arteries from women who had previous abdominal surgery. Scar tissue is extremely 
difficult to dissect, and the resistance arteries tended to either be too small, or were 
embedded in thick fibrous tissue that was very difficult to remove without vessel 
damage. Furthermore, abdominal subcutaneous fat appears to be less vascular 
compared to, gluteal subcutaneous fat, for example, posing problems in arterial 
identification and isolation.
Further investigation of the action of insulin following endothelial denudation 
should ideally also have been carried out in the non-pregnant group, as this may
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have helped explain some of the mechanisms involved. Similarly, studying a group 
of type 1 diabetic non-pregnant women would have given further indication of the 
effects of pregnancy and diabetes on the control of vascular function, but was 
unfortunately not included in the study. Although this was considered, there was 
difficulty recruiting sufficient age-matched non-pregnant women and young type 1 
diabetic women undergoing laparotomy within the period of research. The 
alternative solution of performing gluteal biopsies on these young diabetic women 
had not been originally planned and therefore organisational elements such as 
research unit booking and ethical permission were not in place.
Other omissions were serial measurements of plasma endothelin-1 levels and 
glycosylated haemoglobin, which, along with other blood analyses could have been 
related to the in vitro assessments of vascular function, and provided valuable 
information.
6.2 Future Research
Although this study has identified some of the factors important in the control of 
vascular tone in human subcutaneous resistance arteries, greater mechanistic insight 
is still required. The following areas based on the work in this thesis are worthy of 
further research.
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6.2.1 The mechanism(s) underlying the vasodilatory effect of insulin in 
pregnancy
The vasodilatory effect of insulin is maintained in pregnancy, and attenuates 
vasoconstriction via an endothelium-independent mechanism. Its mode of action 
may possibly be secondary to activation of the Na^/K^-ATPase or Ca^^-ATPase 
pumps, or via the (3-adrenoceptors as previously suggested. The identification of 
the mechanism(s) underlying this effect of insulin would involve a step-wise 
inhibition of each of the known possible pathways, following endothelial 
denudation.
The ability of insulin to attenuate vasoconstriction responses has been shown to 
vary depending on the patient group and vascular bed studied. The extension of this 
study to include type 1 diabetic non-pregnant women is important. This would 
outline the effect of both pregnancy and diabetes on insulin action, and may provide 
some insight into the pathophysiology surrounding the increased incidence of 
pregnancy-induced hypertension in diabetic women.
6.2.2 Alterations in endothelin-1 receptor expression/density in pregnant 
women with diabetes
Pregnant women with and without type 1 diabetes have demonstrated significant 
differences in vascular responses to endothelin-1 (ET-1), with a potentiation of the 
maximum ET-1 response in healthy pregnant compared to non-pregnant women.
142
and a reduction in sensitivity to ET-1 in diabetic compared to non-diabetic pregnant 
women.
This merits further research, with changes in receptor density/expression, alterations 
in receptor signalling or modifications in peptide uptake mechanisms being possible 
explanations for these observations. ET-1 has been implicated in pre-eclampsia, 
hypertension and cardiac failure. A greater understanding of ET-1 pharmacology in 
pregnancy and diabetes may provide potential therapeutic targets aimed at reducing 
the incidence of hypertension in pregnant women with and without diabetes.
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Appendix II
Presentations
Oral presentations
1. Endothelin-mediated responses in pregnant diabetics.
Presented to the Glasgow Obstetrical and Gynaecological Society.
Glasgow, UK. 17 January 2001.
2. Alterations in endothelin-mediated responses in pregnancy and diabetes. 
Presented to the Scottish Society of Experimental Medicine.
Edinburgh, UK. 27 October 2000.
3. Vascular effects of insulin in pregnancy.
Presented to the Scottish Society of Experimental Medicine.
Glasgow, UK. 26 May 2000.
4. The effect of insulin on small vessel contractility in normal pregnancy. 
Presented at the 19^  ^World Congress of the International Union of Angiology. 
Ghent, Belgium. 4 May 2000.
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Poster presentations
1. EDHF in pregnant women with and without type 1 diabetes. (Second prize 
winner)
Presented to the Scottish Society of Experimental Medicine.
Aberdeen, UK. 4 May 2001.
2. Sensitivity to endothelin is reduced in pregnant diabetic women.
Presented at the 48* Annual Meeting of the Society for Gynecologic 
Investigation. Toronto, Canada. 14-17 March 2001.
3. Endothelin-induced vasoconstriction is increased in pregnancy.
Presented at the 48* Annual Meeting of the Society for Gynecologic 
Investigation. Toronto, Canada. 14-17 March 2001.
4. Insulin resistance in pregnancy does not abolish the effect of insulin on small 
vessel contractility.
Presented at the 19* Joint Meeting of the British Endocrine Societies with the 
European Federation of Endocrine Societies.
Birmingham, UK. 13-16 March 2000.
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